Global High-Priority Regulatory Events — March 02, 2026

02-03-2026

First Bancorp announced that Michael G. Mayer retired as President of the Company and Chief Executive Officer of First Bank effective February 28, 2026, as part of its succession plan. Mr. Mayer will continue serving as a director on the Boards of Directors of both the Company and First Bank. The 8-K filing was signed by Richard H. Moore, Chief Executive Officer, on March 2, 2026.

02-03-2026

Siti Networks Limited disclosed defaults on term loan installments due January 31, 2026, to lenders including ARCIL, IDBI Bank, RBL, Axis Bank, ABFL, IndusInd Bank, Vani Agencies Pvt. Ltd., and ICNCL, with total outstanding claims ranging from ₹1,206 Cr to ₹1,500 Cr. The company remains under Corporate Insolvency Resolution Process (CIRP) initiated on February 22, 2023, with ongoing Supreme Court appeals staying fund remittances to the corporate debtor by financial creditors. No repayments have occurred as the default continues beyond 30 days.

• ·CIRP admission order by NCLT dated February 22, 2023; Public Announcement on February 25, 2023.
• ·NCLAT stayed Admission Order on March 7, 2023; dismissed appeal on August 10, 2023.
• ·NCLT order on October 1, 2024, fixing insolvency commencement at February 22, 2023.
• ·NCLAT judgment on July 31, 2025, dismissing lender appeals; Supreme Court stay currently in place preventing remittances.
• ·VAPL claim assigned from ZEEL on July 2, 2024, admitted as related party financial debt.

02-03-2026

Income Tax Department conducted search proceedings at Greenpanel Industries Limited's registered office, other offices, plant locations, promoter's residence, and an ex-employee's residence from February 26, 2026 (6:25 A.M.) to March 2, 2026 (7:00 P.M.). Certain books of accounts, documents, and digital data were seized during the raids led by Deputy/Assistant Director of Income Tax (Investigation), New Delhi. The company fully cooperated, but details of alleged violations and any financial/operational impact remain unascertainable at this stage.

• ·Search locations: (1) DLF Downtown, Block 3, 1st Floor, DLF Phase 3, Sector 25A, Gurugram; (2) Thapar House, 2nd Floor, 163 S.P. Mukherjee Road, Kolkata; (3) Plot No. 2, Sector 9, IIE, Pant Nagar, SIDCUL, Rudrapur; (4) Survey No. 97/1, 98/1, 99/1, Routhusuramala, Srikalahasthi; (5) 10, Maulsari Avenue, Westend Green Farms, Rajokri, Southwest Delhi; (6) Flat No. 2NW, 2nd Floor, 5 Queens Park, Ballygunge, Kolkata; (7) Diamond City South, Tower-4, Flat-7D/7E, 58 M.G. Road, Karunamoyee, Kolkata.
• ·Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, and SEBI Circular dated November 11, 2024.

02-03-2026

The Board of Directors of California Software Company Limited approved an extension of the deadline for payment of the First and Final Call of ₹7.50 per partly paid-up equity share, originally due March 02, 2026, to March 11 - May 08, 2026, with 10% p.a. interest applicable from the original due date due to shareholder requests and market liquidity conditions. The Record Date of February 05, 2026, remains unchanged. Partly paid-up shares under ISIN IN9526B01012 will continue to be suspended from trading until completion of the process.

• ·ISIN IN9526B01012 representing partly paid-up equity shares remains suspended from trading.
• ·Scrip Codes: NSE - CALSOFT, BSE - 532386.
• ·Board meeting commenced at 05:30 P.M. and concluded at 07:30 P.M. on March 02, 2026.
• ·Detailed Extension Notice to be dispatched to eligible shareholders and available on company, registrar, and stock exchange websites.

02-03-2026

Ansal Housing Limited disclosed a default on repayment of principal amount of ₹49.64 Crores to Suraksha Asset Reconstruction Private Limited (as Trustee of Suraksha ARC-034 Trust) on 31 January 2026, related to project funding. The total obligation stands at ₹169 Crores (secured, 14% p.a. interest, repayable in monthly instalments till 31 December 2026), with outstanding borrowings from banks/financial institutions at ₹208.52 Crores and total financial indebtedness at ₹233.12 Crores. No interest default was reported.

• ·Nature of obligation: Project Funding
• ·Tenure: Repayment in monthly instalments till 31 December 2026
• ·Rate of Interest: 14% p.a.
• ·Secured/Unsecured: Secured
• ·Disclosure made on 02 March 2026, per SEBI Master Circular dated 30 January 2026

02-03-2026

Euro Pratik Sales Limited has listed its equity shares on the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE). The company's Corporate Identification Number (CIN) has been updated from U74110MH2010PLC199072 to L74110MH2010PLC199072, and its listing status on the Ministry of Corporate Affairs (MCA) Master Data has changed from 'No' to 'Yes'. This disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

• ·Scrip Code: 544519
• ·Symbol: EUROPRATIK
• ·Old CIN: U74110MH2010PLC199072
• ·New CIN: L74110MH2010PLC199072
• ·DIN: 00408876

02-03-2026

Acquirers, including Radhe Dhokla Private Limited and four individuals, are launching an open offer to public shareholders of Shantai Industries Limited to acquire up to 19.20 Lakh equity shares (25.60% of voting share capital) at ₹21 per share, aggregating ₹4.03 Cr, pursuant to SEBI (SAST) Regulations for substantial acquisition and change in control. The offer size is restricted to public shareholding, falling slightly short of the minimum 26% requirement. The tendering period opens on April 16, 2026, and closes on April 29, 2026, with no minimum acceptance condition or competing offers noted.

• ·Scrip Code: 512297
• ·No statutory approvals required as per acquirers' knowledge; offer withdrawable if approvals denied
• ·Offer not conditional on minimum acceptance; proportionate acceptance if oversubscribed
• ·Target Company CIN: L46411GJ1988PLC013255 (process underway to correct to reflect 1985 incorporation, application rejected Feb 25, 2026)
• ·Identified Date: March 30, 2026
• ·Marketable lot: 1 share

02-03-2026

Go Fashion (India) Limited completed the buyback of 14,13,000 equity shares at ₹460 per share through the tender offer route, for an aggregate consideration of ₹64.998 Cr (excluding transaction costs and taxes). The tendering period was from February 13, 2026, to February 20, 2026, with the record date on February 9, 2026. A post-buyback public announcement was published on March 2, 2026, in Financial Express (English), Makkal Kural (Tamil), and Jansatta (Hindi).

• ·Scrip Code: 543401; Trading Symbol: GOCOLORS
• ·Intimation of Letter of Offer dispatch: February 11, 2026
• ·Newspapers for announcement: Financial Express (English), Makkal Kural (Tamil), Jansatta (Hindi)

28-02-2026

The National Company Law Tribunal (NCLT), Kolkata Bench, approved the Scheme of Amalgamation of Mal Metalliks Private Limited (step-down wholly owned subsidiary) and Multitech Auto Private Limited (wholly owned subsidiary) with Ramkrishna Casting Solutions Limited (formerly JMT Auto Limited, wholly owned subsidiary) of Ramkrishna Forgings Limited, effective from the Appointed Date of January 1, 2024. The order was pronounced on February 27, 2026, following board approvals on February 16, 2024, and April 7, 2025, with the scheme expected to become effective upon filing the certified copy with the Registrar of Companies, Kolkata. The amalgamation aims to achieve synergies, cost efficiencies, streamlined operations, and better resource utilization without any reported drawbacks.

• ·BSE Scrip Code: 532527; NSE Symbol: RKFORGE
• ·CINs: Mal Metalliks (U27109WB2005PTC102386), Multitech Auto (U34102WB2004PTC215505), Ramkrishna Casting Solutions (U42274WB1997PLC277411)
• ·Prior intimation dated November 07, 2025; NCLT petition heard January 22, 2026
• ·Parent acquired transferor companies via share purchase agreement July 21, 2023; transferee via IBC resolution plan order August 21, 2023 from NCLT New Delhi
• ·Valuation report dated February 15, 2024; Statutory auditor certificate April 12, 2025
• ·Meetings of shareholders/creditors dispensed with per order September 3, 2025; petition admitted October 7, 2025

02-03-2026

Suzlon Energy Limited reported a Material Price Movement (MPM) in its scrip on March 2, 2026, at 9:30 a.m., as per Regulation 30(11) of SEBI (LODR) Regulations 2015. The company confirmed no event or information in mainstream media was identified as the trigger for this movement. This disclosure was made to the National Stock Exchange of India Limited and BSE Limited.

• ·Disclosure addresses exchanges at 'Exchange Plaza', P.J. Towers, Bandra-Kurla Complex, Bandra (East), Mumbai and Dalal Street, Mumbai.

28-02-2026

Sayaji Hotels (Indore) Limited informed BSE on February 28, 2026, that Ujaas Energy Limited has filed an application to withdraw its Section 9 IBC insolvency petition, originally intimated on August 21, 2025, following execution of a Settlement Deed referenced in a February 27, 2026 intimation. The NCLT Indore Bench order for withdrawal and dismissal of the petition is awaited, with the company committing to further updates on outcomes.

• ·Petition filed under Section 9 of Insolvency and Bankruptcy Code, 2016 before NCLT Indore Bench.
• ·Withdrawal application under Rule 8 of Insolvency and Bankruptcy (Application to Adjudicating Authority) Rules, 2016 read with Rule 11 of NCLT Rules, 2016.

28-02-2026

Anupam Rasayan India Limited, a promoter holding 25.80% in TANFAC Industries Limited, created an encumbrance in the form of a non-disposal undertaking on its entire 25,73,081 shares (49.79% of total promoter holding) on February 20, 2026, in favor of Catalyst Trusteeship Limited as security for a USD 20 million loan to its Luxembourg subsidiary Doriath S.À R.L. The shares provide a security cover of ₹1,106.50 Cr against the loan, yielding a 6.08:1 ratio, with proceeds used for acquiring Monitchem Kansas S.À R.L. and subsidiaries. This represents nearly 26% of TANFAC's total share capital being pledged, posing potential risks to promoter control amid an ongoing share sub-division.

• ·Encumbrance created on February 20, 2026; reported February 28, 2026.
• ·Share sub-division approved by TANFAC board on January 9, 2026, and members on February 23, 2026 (1:10 FV share to 2:5 FV shares).
• ·Loan issuer Doriath S.À R.L. is wholly-owned subsidiary of Anupam Rasayan; unlisted senior secured notes, no credit rating.
• ·Catalyst Trusteeship acts as onshore security trustee for offshore lender Altis XII Pte. Ltd.

28-02-2026

Promoter group of India Finsec Limited disclosed the release of pledge on equity shares pursuant to Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The letter was addressed to BSE Limited on February 27, 2026, with a copy to the company. No quantitative details on shares released or values were provided in the legible portions of the filing.

• ·Scrip Code: 535667
• ·Company Address: D-16, 1st Floor, Above ICICI Bank, Prashant Vihar, Sector-14, Rohini, New Delhi-110085
• ·Email: indtafinsec@gmail.com

28-02-2026

Refex Holding Private Limited, a promoter holding 7.65 Cr shares (55.80%) in Refex Industries Limited, created a pledge on an additional 50.45 lakh shares (3.67% of total share capital) on February 25, 2026, increasing its encumbered shares from 2.66 Cr (19.40%) to 3.16 Cr (23.07%). This brings the total promoter group encumbrances to 3.16 Cr shares (41.34%), securing debentures issued by subsidiary Refex Life Sciences Pvt. Ltd. to Touchstone Trust Scheme VI via Catalyst Trusteeship Limited. Multiple prior encumbrances exist, with pledged shares exceeding 20% of total share capital, signaling potential liquidity pressures on promoters.

• ·Pledge created for collateral on unrated, unlisted debentures of Refex Life Sciences Pvt. Ltd. (face value ₹10 lakh each).
• ·Security cover ratio for new pledge: 0.85:1.
• ·Other encumbrances include pledges to non-bank entities for personal use by promoters.
• ·Encumbered shares >20% of total share capital: Yes; >50% of promoter holding: No.

02-03-2026

RBI reported zero volumes across all overnight and term money market segments on March 1, 2026, indicating dormant activity. Today's LAF operations resulted in net liquidity absorption of ₹2,99,653 Cr primarily via SDF, leading to an overall net liquidity absorption of ₹2,12,622 Cr including outstanding operations. Scheduled commercial banks' cash balances stood at ₹8,22,675 Cr against an average CRR requirement of ₹7,63,554 Cr, with net durable liquidity surplus at ₹5,60,171 Cr as of February 15, 2026.

• ·No transactions (zero volume) in Call Money, Triparty Repo, Market Repo, Repo in Corporate Bond, Notice Money, Term Money.
• ·MSF rate: 5.50%; SDF rate: 5.00%; Outstanding repo rates: 5.34% and 5.26%.
• ·Government of India surplus cash balance: ₹0 Cr as on Feb 27, 2026.

02-03-2026

Mahindra & Mahindra's associate, Mitsubishi Mahindra Agricultural Machinery Co., Ltd. (MAM), approved withdrawal from its agricultural machinery business by the first half of fiscal year 2027 due to persistent losses and challenges in long-term viability, while continuing spare parts supply and warranty services. MAM reported FY25 revenue of ₹2,094.17 Cr (1.13% of M&M consolidated turnover post-adjustments) but incurred a PAT loss of ₹227.42 Cr (-1.17% of consolidated PAT), with negative net worth of ₹(17.74) Cr (-0.02% consolidated). The restructuring benefits the promoter group by avoiding future annual losses and funding obligations.

• ·MAM board approval date: March 2, 2026
• ·Business withdrawal timing: first half of fiscal year 2027
• ·Intimation received by M&M: March 2, 2026 at 12:34 p.m. IST
• ·Inquiry period for MAM release: March 2, 2026 to March 31, 2026

02-03-2026

HBT Financial, Inc. completed its merger with CNB Bank Shares, Inc. on March 2, 2026, integrating CNB's $1.8B total assets, $1.3B loans held for investment, and $1.5B deposits (as of Dec 31, 2025) into HBT's $5.1B asset base, $3.5B loans, and $4.4B deposits, expanding its footprint in central Illinois, Chicago MSA, and St. Louis MSA markets. The merger also led to the appointment of James T. Ashworth and Nancy L. Ruyle as new directors to HBT Financial and Heartland Bank boards, effective March 1, 2026, with terms expiring at the 2026 Annual Meeting. No financial performance declines or flat metrics were reported in the announcement.

• ·HBT Financial provides financial products and services through 66 full-service branches in Illinois and eastern Iowa.
• ·Peter Chapman designated as IR contact: HBTIR@hbtbank.com, (309) 664-4556.

02-03-2026

Kosmos Energy reported Q4 2025 net production of ~67,900 boepd, up ~4% QoQ, with revenues of $295 million, but posted a net loss of $377 million ($0.79/share) including $144 million write-off and $178 million impairments, with adjusted net loss of $78 million ($0.16/share). Year-end 1P reserves stood at ~250 mmboe (10-year life, 90% replacement ratio) and 2P at ~500 mmboe (20-year life, -18% replacement), bolstered by Ghana license extensions to 2040, while FY capex of $292 million was 25% below guidance. Key post-quarter moves included a $350 million bond offering, redemption of 2026 notes, TEN FPSO acquisition for opex savings, and sale of Equatorial Guinea assets for up to $220 million to accelerate debt reduction from $3.0 billion net debt.

• ·GTA production: Dec 2025 ~2.7 mtpa equivalent, 2026 YTD ~2.9 mtpa; Q4 net ~14,200 boepd.
• ·Jubilee: Current gross >70,000 bopd; J74 well ~13,000 bopd; J75 ~40m net pay, online Q1 2026 end.
• ·Equatorial Guinea sale details: Upfront $180M (adj.), contingents $12.5M (performance) + $9M/yr 2027-2029 (oil price/prod thresholds); effective Jan 1, 2025, close mid-2026.
• ·Hedges: 2026 8.5M bbl floor ~$66/bbl; 2027 2.0M bbl floor ~$60/bbl.
• ·Liquidity at Dec 31, 2025: $92M cash, $150M RBL undrawn, $100M Term Facility undrawn.
• ·Overhead reductions FY 2025: >$25M.
• ·FY 2026 capex guidance: ~$350M (~2/3 to Jubilee drilling).

02-03-2026

Eaton Corporation plc (NYSE:ETN) announced the appointment of David Foster as Executive Vice President and Chief Financial Officer effective March 2, 2026, succeeding Olivier Leonetti who will depart on March 13, 2026, as part of a planned transition. Foster rejoins after a 29-year career with Eaton, bringing expertise in finance, operations, and markets during a period of unprecedented demand and growth. The company reported $27.4B in revenues for 2025 while serving customers in 180 countries.

• ·Foster previously held roles in FP&A, Controllership, Corporate Development, Treasury, M&A, and was SVP Finance and Planning, Industrial Sector before retiring in 2022.
• ·Foster holds a bachelor’s degree from the University of Michigan and a master’s degree in Manufacturing Management from Kettering University.
• ·Eaton founded in 1911.

02-03-2026

Malibu Boats, Inc. (MBUU) acquired Saxdor Yachts for approximately $175M (EUR 150M), consisting of $130M cash and $45M in stock, with up to $84M earnout, at a 7.2x estimated EBITDA multiple. The deal targets the $2.5B adventure dayboat market growing at 15% CAGR, with Saxdor achieving 65% YoY constant currency revenue growth in calendar 2025 and projected $225-235M revenue for the 12 months ending March 31, 2026, at 10-11% EBITDA margins. The acquisition is immediately accretive to EPS and adjusted EBITDA margins, reaffirms FY2026 guidance for legacy business, and results in pro forma net leverage of 1.5x.

• ·Saxdor founded in 2019 in Helsinki, Finland, with facilities in Finland and Poland.
• ·Acquisition closes March 2, 2026; Saxdor operates as subsidiary maintaining brand autonomy.
• ·Pro forma net leverage of 1.5x vs. maximum 2.5x.
• ·North America represents 33% of Saxdor revenue despite 67% of world's high-net-worth adults.

02-03-2026

Zymeworks Inc. announced a $250 million non-dilutive royalty-backed note financing from Royalty Pharma, secured by 30% of worldwide tiered royalties on Ziihera from Jazz Pharmaceuticals and BeOne Medicines, while retaining 70% of royalties during repayment and full rights thereafter. Proceeds will strengthen the balance sheet, fund stock repurchases at a perceived discount to intrinsic value, support potential strategic acquisitions, and extend cash runway beyond 2028. Zymeworks retains all milestone payments, including up to $1.5 billion in potential regulatory and commercial milestones.

• ·Repayment to Royalty Pharma from low to mid-single digit tiering royalties up to pre-specified limit, ceasing at 1.65x note by Dec 31, 2033 or 1.925x thereafter.
• ·Jazz royalties: tiered 10% to high teens on global sales (ex-Asia excl. Japan, Australia, NZ) up to $2.0B, 20% above.
• ·BeOne royalties: mid-single to mid-double digits up to $1.0B annual net sales, 19.5% above; holds marketing rights in Asia (ex-Japan), Australia, NZ.
• ·All regulatory and commercial milestones retained by Zymeworks.

02-03-2026

Kairos Pharma, Ltd. (NYSE American: KAPA) announced binding terms to acquire exclusive worldwide rights to CL-273, a next-generation AI-designed pan-EGFR inhibitor for EGFR-mutant NSCLC, from OrbiMed and Torrey Pines-backed Celyn Therapeutics, targeting a $16.2B market opportunity in 2026. CEO John Yu described the transaction as value-accretive and pivotal for expanding the oncology pipeline with a potentially best-in-class asset addressing resistance in lung cancer. No financial terms of the deal were disclosed, and completion remains subject to risks outlined in forward-looking statements.

• ·CL-273 is a reversible, wild-type-sparing small-molecule inhibitor targeting resistant EGFR mutations in NSCLC.
• ·EGFR mutations occur in 10-15% of Western NSCLC cases and up to 50% in Asian populations.
• ·Celyn Therapeutics focuses on small-molecule oncology drugs including EGFR- and c-MET-pathway inhibitors.
• ·ENV-105 is in Phase 2 for castrate-resistant prostate cancer and Phase 1 for NSCLC; not yet FDA-approved.
• ·D. Boral Capital, LLC acted as sole financial advisor.

02-03-2026

Teradata Corporation expanded its Board from nine to ten directors and elected Melissa Fisher as a Class I director effective March 1, 2026, appointing her to the Audit Committee and Nominating and Governance Committee as an Audit Committee Financial Expert. This follows a Cooperation Agreement with Lynrock Lake parties announced on February 11, 2026. Director Daniel Fishback will retire at the 2026 Annual Meeting with no disagreements on company matters.

• ·Ms. Fisher determined independent under NYSE and SEC requirements.
• ·No other arrangements or Item 404(a) transactions involving Ms. Fisher.
• ·Mr. Fishback has served since 2017 and remains on Compensation and People Committee until retirement.
• ·Proxy statement describing compensation program filed March 27, 2025.

02-03-2026

On March 1, 2026, Our Bond, Inc. (OBAI) amended warrants originally issued October 27, 2025, reducing the exercise price for 12,000,000 shares from $12.35 to discounted levels of $2.25 (4.5M shares), $2.75 (3.75M shares), and $3.25 (3.75M shares) for 90 days, after which it reverts to $12.35; 15,991,902 shares remain purchasable overall. Simultaneously, the company issued a $2.5M promissory note to Ascent Partners Fund, LLC at 10% interest, maturing September 1, 2026, requiring 25% of future securities offering proceeds toward repayment, with default penalties including 24% interest. This provides short-term financing but introduces dilution risk from lower warrant prices and debt obligations.

• ·Warrant original expiration: July 27, 2026
• ·Note events of default include failure to pay principal/interest within 5 business days, covenant breaches, defaults on indebtedness over $150,000, or change of control
• ·All other warrant terms unchanged post-amendment

02-03-2026

Rein Therapeutics, Inc. (RNTX) entered into a Securities Purchase Agreement dated February 2026 to sell an unsecured promissory note to a purchaser, as part of a series of notes with an aggregate principal amount of up to $5.5M, including a prior $2.5M note issued in January 2026. The notes include a 20% original issue discount on the purchase price. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Agreement closing to occur no earlier than first Business Day after February 2026 and no later than fifth Business Day after.
• ·SEC filing date: March 02, 2026.
• ·Exemption under Section 4(a)(2) of Securities Act and Rule 506 of Regulation D.

02-03-2026

KinderCare Learning Companies, Inc. filed an 8-K on March 02, 2026, disclosing that on February 26, 2026, its Compensation Committee approved the KinderCare Learning Companies, Inc. Short Term Incentive Plan, effective January 4, 2026. The Plan governs annual performance-based cash bonus awards for selected officers and employees, tied to financial, operational, and strategic metrics determined by the Committee. No specific performance targets, award amounts, or participant details were disclosed in the filing.

• ·Plan attached as Exhibit 10.1
• ·Compensation Committee has authority to adjust awards for unusual or non-recurring events

02-03-2026

EQV Ventures Acquisition Corp. (NYSE: FTW) shareholders approved the business combination with Presidio Investment Holdings LLC, a mature oil and gas operator, at an extraordinary general meeting on February 27, 2026. The transaction is expected to close on or about March 4, 2026, subject to closing conditions, with shares of the combined entity to trade on NYSE under 'FTW' starting March 5, 2026. Presidio anticipates providing dividend details post-closing, highlighting its capital-light platform for shareholder returns, though dividends are not guaranteed and subject to various risks.

• ·EQV sponsored by affiliate of EQV Group, formed in 2022.
• ·Presidio headquartered in Fort Worth, TX, focused on Mid-Continent operations.
• ·A Form 8-K with full voting results to be filed with SEC.
• ·Contacts: Presidio@icrinc.com; IR@eqvventures.com

02-03-2026

Crane Harbor Acquisition Corp. (CHAC), a SPAC, filed a definitive proxy statement (DEFM14A) on March 2, 2026, for an extraordinary general meeting on March 19, 2026, seeking approval for its business combination with Xanadu Quantum Technologies Inc. (Old Xanadu) via Xanadu Quantum Technologies Limited (NewCo), including SPAC's continuance from Cayman Islands to Ontario and share exchanges under a Plan of Arrangement dated November 3, 2025. The transaction contemplates issuance of 515,387,046 NewCo Class A Multiple Voting Shares and 79,747,482 Class B Subordinate Voting Shares, alongside PIPE financing at $10.00 per share from investors including affiliates of Crane Harbor Sponsor, LLC. No prior period financial performance data or metrics are disclosed in the filing.

• ·Business Combination Agreement dated November 3, 2025, between Crane Harbor Acquisition Corp., Xanadu Quantum Technologies Limited (NewCo), and Xanadu Quantum Technologies Inc. (Old Xanadu).
• ·Extraordinary General Meeting on March 19, 2026, at 10:00 a.m. Eastern Time, held virtually.
• ·Proposals for vote: Business Combination Proposal (Proposal No. 1), Continuance Proposal (Proposal No. 2), Adjournment Proposal (Proposal No. 3).
• ·SPAC Rights to be exercised for 1/10 of one SPAC Class A Share prior to Closing.
• ·NewCo intends to list Class B Subordinate Voting Shares on Nasdaq and TSX post-Closing.

02-03-2026

EACO Corp filed an 8-K on March 2, 2026, disclosing entry into a material definitive agreement under Item 1.01 and the creation of a direct financial obligation under Item 2.03, with related financial statements and exhibits under Item 9.01. No specific financial metrics, amounts, or performance comparisons were detailed in the filing notice. This represents a material event potentially impacting the company's capital structure.

• ·Filing CIK: 0000784539
• ·SIC: 5065 - WHOLESALE-ELECTRONIC PARTS & EQUIPMENT, NEC
• ·Fiscal Year End: August 31
• ·Business Address: 5065 E Hunter Ave, Anaheim, CA 92807

02-03-2026

Chaince Digital Holdings Inc. (CD) entered into a Securities Purchase Agreement on February 25, 2026, to sell 6,500,000 ordinary shares at $0.774 per share to non-U.S. investors for a total of $5.03M, under Regulation S exemption. The offering is expected to close on or before March 12, 2026. No financial performance metrics or period comparisons were reported.

• ·Securities registered: Common Shares, par value US$0.004 per share, trading symbol CD
• ·Exemption relied upon: Rule 903 of Regulation S under the Securities Act of 1933
• ·Principal executive offices: 1251 Avenue of the Americas, Fl 41, New York, NY 10019

02-03-2026

On February 27, 2026, ProCap Financial, Inc. completed the acquisition of 450 Bitcoin via the assignment of previously entered put option contracts with FalconX Bravo, Inc., dated January 5 and January 20, 2026. The transaction utilized approximately $35.4 million in net capital sourced from the company's working capital account. No additional financial impacts, declines, or comparative data were disclosed.

• ·Option contracts entered in ordinary course of business
• ·Securities traded on The Nasdaq Stock Market LLC under symbols BRR and BRRWW
• ·Registrant is an emerging growth company

02-03-2026

Paloma Acquisition Corp I, a blank check company (SPAC), completed its IPO on February 20, 2026, raising $150M in gross proceeds from 15M public units at $10 each, with proceeds held in trust; simultaneously sold 500K private placement units for $5M. The balance sheet as of February 20 shows total assets of $151.6M including $150M trust cash, but a shareholders' deficit of $4.7M due to offering costs and transaction expenses of $9.5M. On February 25, 2026, it closed an over-allotment of 1.45M units for additional $14.5M gross proceeds.

• ·Business Combination must target businesses with fair market value at least 80% of Trust Account net assets.
• ·Completion Window: 24 months from IPO closing (February 20, 2026).
• ·Sponsor purchased 350K of 500K Private Placement Units; underwriters purchased 150K.
• ·562,500 Class B shares subject to forfeiture if over-allotment not exercised (but it was).

02-03-2026

On February 26, 2026, Tilly’s, Inc. amended its Third Amended and Restated Tilly's 2012 Equity and Incentive Award Plan to increase the maximum aggregate shares of Class A common stock per person per calendar year to 2,500,000 shares. Concurrently, the company canceled and re-granted to President and CEO Nathan Smith time-based options for 900,000 shares and performance-based options for 900,000 shares, originally issued in September 2025, under identical terms including exercise price, vesting, and expiration.

• ·Amendment filed as Exhibit 10.1.
• ·Original options granted to Nathan Smith in September 2025 upon commencement of employment.
• ·Event reported on February 26, 2026; filing signed February 27, 2026.

02-03-2026

Roblox Corporation disclosed that Arvind K. Chakravarthy, its Chief People and Systems Officer, notified the company of his resignation effective March 6, 2026, to pursue other opportunities. The resignation was announced on February 24, 2026, with no details provided on a successor or any related compensatory arrangements.

• ·Filing submitted on March 2, 2026, reporting the earliest event on February 24, 2026.

02-03-2026

Analysis unavailable

02-03-2026

Paramount Skydance Corporation (PSKY) announced a definitive agreement to acquire Warner Bros. Discovery, Inc. (WBD) for $31.00 per share in cash, valuing WBD at $81B equity value and $110B enterprise value, funded by $47B in new Class B shares at $16.02 per share from the Ellison Family and RedBird Capital Partners, plus $54B in debt commitments. The deal, unanimously approved by both boards, is expected to close in Q3 2026 with over $6B in projected synergies and a net debt-to-EBITDA of 4.3x at close, unlocking expanded content libraries, streaming platforms, and sports rights. No historical declines or flat metrics are reported, positioning the combined entity for growth in DTC and theatrical releases with a minimum of 30 films annually.

• ·Expected net debt-to-EBITDA of 4.3x at closing, with path to investment grade within three years.
• ·Shareholder vote for WBD expected in early spring 2026.
• ·Conference call and webcast on March 2, 2026 at 8:30am ET.
• ·Transaction not subject to financing conditions; prior tender offer terminated.

02-03-2026

BioAtla, Inc. announced a formal strategic review process to explore options like asset sales, licensing, or partnerships to maximize shareholder value, engaging Tungsten Advisors as financial advisor. Concurrently, the company is implementing a major restructuring, including a ~70% workforce reduction and cost-containment measures while retaining essential staff and continuing select clinical trials like Phase 1 for BA3182. No assurance of any transaction outcome, amid going concern doubts and need for funding.

• ·Clinical pipeline includes Phase 3 Ozuriftamab vedotin in OPSCC, Phase 2 Mecbotamab vedotin in sarcoma/mKRAS NSCLC and Evalstotug in melanoma.
• ·Preclinical assets: BA3361 (IND-approved), BA3151, BA3142 (IND-ready), BA3311, BA3241.
• ·FDA Fast Track Designation for Ozuriftamab vedotin in recurrent/metastatic SCCHN.
• ·Ongoing Phase 1 study for BA3182 in advanced adenocarcinoma.
• ·References going concern doubts and need for additional funding.

02-03-2026

enCore Energy Corp. announced the retirement of founder William M. Sheriff as Executive Chair and Director, effective March 2, 2026; he transitions to Chairman Emeritus and Senior Advisor on the Technical Advisory Committee while accepting the role of Executive Chair at Verdera Energy Corp. enCore, the largest shareholder of Verdera, plans to distribute Verdera common shares to its shareholders following the effectiveness of Verdera's resale registration statement, as previously noted on February 18, 2026. The company is participating in PDAC 2026, presenting at the Investor Forum on March 3 at 3:32 p.m. ET.

• ·enCore operates two Central Processing Plants in South Texas.
• ·enCore holds non-core assets and proprietary databases.
• ·PDAC 2026 attendance: March 1-3, 2026, in room 801A for presentation.

02-03-2026

DNA X, Inc. (formerly Sonim Technologies, Inc., ticker SONM) completed the acquisition of 100% membership interests in DNA X LLC from DNA Holdings Venture, Inc. on December 15, 2025, for 223,201 shares of its common stock, representing 19.99% of outstanding shares. This 8-K/A filed on March 2, 2026, amends the original December 18, 2025 filing to clarify that the transaction does not constitute a 'significant amount of assets' under Item 2.01, eliminating the need for financial statements or pro forma information.

• ·Original 8-K filed December 18, 2025
• ·Registrant address: 4445 Eastgate Mall, Suite 200, San Diego, CA 92121

02-03-2026

Apellis Pharmaceuticals, Inc. elected Mikael Dolsten, M.D., Ph.D., as an independent Class I director effective March 1, 2026, to serve until the 2027 annual stockholder meeting. Dr. Dolsten will receive standard non-employee director compensation, including a stock option and RSUs each with a Black-Scholes valuation of $300,000 under the 2017 Stock Incentive Plan. No family relationships, related transactions, or committee appointments were noted.

• ·Option vests one-third annually over three years; RSUs vest fully after one year, with deferral option.
• ·Both awards accelerate fully upon change in control.
• ·Election recommended by Nominating and Corporate Governance Committee on February 27, 2026.

02-03-2026

A consortium led by Global Infrastructure Partners (GIP) and EQT has agreed to acquire AES for $15.00 per share in cash, equating to a $10.7B equity value and $33.4B enterprise value, representing a 40.3% premium to the 30-day VWAP prior to July 8, 2025. The deal addresses AES's capital needs for growth beyond 2027, avoiding potential dividend reductions or significant equity issuances, while maintaining operations of AES Indiana and AES Ohio as regulated utilities. Transaction expected to close in late 2026 or early 2027, subject to approvals.

• ·Consortium to fund 100% of purchase price with equity; no expected impact on regulated utility customer rates.
• ·Fairness opinions provided by J.P. Morgan Securities LLC and Wells Fargo Securities LLC.
• ·AES cancelled Q4 and FY 2025 earnings call scheduled for March 3, 2026; expects to file 10-K on March 2, 2026.
• ·EQT total AUM EUR 270B (EUR 141B fee-generating) as of Dec 31, 2025.

02-03-2026

Shoulder Innovations, Inc. (NYSE: SI) appointed MedTech veteran Drew Hykes to its Board of Directors and Compensation Committee effective February 26, 2026, bringing over 25 years of experience from Inari Medical, Medtronic, and others to support scaling its shoulder arthroplasty portfolio. Concurrently, Independent Director Geoff Pardo resigned after three years of service, with the company expressing gratitude for his contributions. No financial impacts or performance metrics were disclosed.

• ·Drew Hykes served as CEO of Inari Medical from 2023 until its acquisition by Stryker in 2025, and previously as COO and Chief Commercial Officer there.
• ·Hykes led commercialization of WEB Aneurysm Embolization system at Sequent Medical before its acquisition by Terumo.
• ·Contact: Brian Johnston or Sam Bentzinger, Gilmartin Group LLC, ir@shoulderinnovations.com

02-03-2026

GeneDx Holdings Corp. entered into a $100M term loan agreement with Blackstone on February 27, 2026, to fully repay its existing credit agreement dated October 27, 2023, with Perceptive Credit Holdings IV, LP, and support balance sheet optimization and general corporate purposes. The new five-year loan bears interest at Term SOFR plus 4.50% (with a 1.50% floor), is secured by substantially all assets, and includes a $50M minimum liquidity covenant. No performance metrics or declines were reported in the filing.

• ·Term Loan prepayable at option but subject to yield protection premiums and mandatory prepayments on change of control, asset sales, or certain indebtedness.
• ·Obligations guaranteed by certain subsidiaries.
• ·Loan Agreement to be filed as exhibit to Q1 2026 10-Q.

02-03-2026

Jeffrey D. Bitzer will resign as Chief Development Officer of Coronado Global Resources Inc. effective February 28, 2026, following prior disclosure. On February 26, 2026, he entered a part-time Employment Agreement effective March 1, 2026, for a six-month transition period assisting the Board and management, with monthly compensation of $27,000 and eligibility for employee benefits, retained incentives, and a 2025 short-term incentive payment.

• ·Agreement includes eligibility to retain incentive units in Coronado Group LLC and outstanding Performance Share Units, subject to performance metrics
• ·Mr. Bitzer agreed to execute a general release and remains bound by non-disclosure and confidentiality provisions
• ·Short-term incentive payment under 2025 program to be paid in March 2026

02-03-2026

Eton Pharmaceuticals, Inc. (Nasdaq: ETON) announced it has in-licensed U.S. commercialization rights to HEMANGEOL® (propranolol hydrochloride oral solution), the only FDA-approved treatment for proliferating infantile hemangioma, from Pierre Fabre Medicament Sas, effective May 1, 2026. This acquisition achieves Eton's goal of ten commercial rare disease products and is expected to be accretive to 2026 earnings, financed with cash on hand. HEMANGEOL is estimated to treat 5,000-10,000 infants annually in the U.S., with distribution via the Eton Cares™ program offering $0 co-pay for qualifying patients.

• ·Pierre Fabre to commercialize HEMANGEOL in U.S. until April 30, 2026.
• ·HEMANGEOL treatment typically initiated between 5 weeks to 5 months of age and continues for approximately 6 months.
• ·Contact for product info: (847) 787-7361.

02-03-2026

HCW Biologics Inc. (Nasdaq: HCWB) announced on March 2, 2026, that the Nasdaq Hearings Panel determined on February 26, 2026, the Company regained compliance with all continued listing rules for The Nasdaq Capital Market, avoiding delisting. This compliance enables continued access to public markets for capital to advance immunotherapies targeting autoimmune diseases, cancer, and senescence-associated diseases. CEO Dr. Hing C. Wong highlighted the Panel's discretion in providing time to meet the Equity Rule requirements.

• ·Phase 1 study for HCW9302 initiated in November 2025.
• ·Annual Report on Form 10-K filed with SEC on November 14, 2025.
• ·Two licensing agreements for exclusive worldwide rights to proprietary molecules.
• ·Pipeline details available at https://hcwbiologics.com/pipeline/

02-03-2026

Civista Bancshares, Inc. announced that President and CEO Dennis Shaffer will retire effective August 28, 2026, and will be succeeded by Charles 'Chuck' Parcher, current President of Civista Bank, who will assume the roles of President and CEO for both the holding company and bank. Shaffer will remain as Chairman of the Board to ensure a seamless transition after more than 40 years of service. The $4.3B financial holding company operates 44 locations across Ohio, Southeastern Indiana, and Northern Kentucky.

• ·Civista Bank founded in 1884.
• ·Dennis Shaffer has more than 40 years of service in the banking industry.
• ·Common shares traded on NASDAQ Capital Market under symbol 'CIVB'.
• ·Filing date: March 02, 2026.

02-03-2026

UroGen Pharma Ltd. and UroGen Pharma, Inc. entered into a $250M term loan agreement with BPCR Limited Partnership, BioPharma Credit Investments V (Master) LP, and BioPharma Credit PLC, with $200M (Tranche A) funded on February 26, 2026, to refinance $125M existing debt and fund general corporate purposes, while $50M (Tranche B) is available by June 30, 2027. The loans carry 8.25% fixed interest, mature in approximately 5 years, with principal repayments in four quarterly installments starting Q1 2030, subject to fees including 1.5% funding fee and 1% exit fee, secured by substantially all assets, and include restrictive covenants but no financial covenants.

• ·Loan matures on 5th anniversary of Tranche A Closing Date (February 26, 2026).
• ·Prepayments before 1st anniversary subject to makewhole amount equal to interest through that date.
• ·No financial covenants; includes customary restrictive covenants on asset sales, indebtedness, dividends, and change of control.
• ·Obligations guaranteed by UroGen Pharma Ltd. (subject to Israeli law limitations) and secured by substantially all tangible and intangible assets.

02-03-2026

Sabre Corporation adopted a limited-duration Shareholder Rights Plan effective March 1, 2026, expiring February 28, 2027, with a 15% ownership trigger (20% for passive investors) in response to Constellation Software Inc.'s accumulation of a 9.7% economic stake (4.7% beneficial ownership + 5% derivatives) between April and November 2025. Negotiations for a strategic governance agreement, including a board seat for Constellation's Vela Software CEO, neared completion but abruptly ended on February 26, 2026, without explanation, despite Sabre's reengagement attempts. The plan protects shareholders from creeping control without a premium but leaves room for fair offers or resumed talks.

• ·Rights issued one per share as of close of business March 11, 2026
• ·Constellation nomination notice delivered January 23, 2026; withdrew second candidate February 28, 2026
• ·Unusually high trading volume observed week of February 23-27, 2026
• ·Sabre remains open to resuming discussions with Constellation

02-03-2026

Pulmatrix, Inc. announced the termination of its Merger Agreement with Cullgen Inc. on February 28, 2026, following delays in approval from the China Securities Regulatory Commission, after stockholders approved the merger on June 16, 2025. Despite this termination, the company is advancing discussions on alternative merger opportunities and emphasized its iSPERSE™ technology, supported by 149 granted patents as of December 31, 2025, and pipeline assets like Phase 2-ready PUR3100, PUR1800, and partner-advanced PUR1900. No immediate financial impacts or monetization details from the termination were disclosed.

• ·Merger Agreement originally entered November 13, 2024, and amended April 7, 2025.
• ·Form S-4 registration statement filed February 14, 2025, effective May 9, 2025.
• ·Mutually agreed to waive 'No Solicitation' clause in December 2025 press release.
• ·PUR1900 approved for Phase 3 in India by Cipla; Pulmatrix and Cipla share U.S. rights 50/50.

02-03-2026

Farmers National Banc Corp. (FMNB) completed its merger with Middlefield Banc Corp. (MBCN) on March 2, 2026, boosting banking assets to over $7.4B from $5.2B as of December 31, 2025 (42% increase) and expanding branches to 83 from 62. The company added two new board members, Kevin A. DiGeronimo and Michael C. Voinovich, while wealth management assets under care remained at over $4.7B. This marks FMNB's seventh bank acquisition in the last decade, enhancing its footprint in Ohio and Pennsylvania.

• ·Operates 83 branches throughout Ohio and Pennsylvania
• ·Forward-looking statements highlight integration risks and economic uncertainties

02-03-2026

Signing Day Sports, Inc. terminated its At The Market Offering Agreement (ATM Agreement) with H.C. Wainwright & Co., LLC, which was entered into on December 2, 2024, for the offer and sale of common stock. The Company delivered a termination notice on February 27, 2026, effective March 10, 2026, with no sales occurring under the agreement since July 1, 2025. This ends the Company's ability to conduct further ATM offerings.

• ·Agreement originally filed as Exhibit 10.1 to Prior Form 8-K on December 2, 2024
• ·Trading symbol: SGN on NYSE American LLC
• ·No offers or sales of common stock under the ATM Agreement since July 1, 2025

02-03-2026

Intellia Therapeutics, Inc. amended its Open Market Sale Agreement with Jefferies LLC, increasing the total value of Common Shares issuable from $750M to $1,035,316,650, representing a 38% expansion of the ATM offering capacity. The amendment updates the issuance notice reference and changes the company contact from Glen Goddard to Edward Dulac. The company must file a Prospectus Supplement within two business days of March 2, 2026.

• ·Original Sales Agreement dated March 4, 2022, previously amended February 23, 2024
• ·Prospectus Supplement to be filed pursuant to Rule 424(b) within two Business Days
• ·Governed by New York law

02-03-2026

Classover Holdings Inc. (NASDAQ:KIDZ, KIDZW) terminated its $400M Equity Purchase Facility Agreement with Solana Strategic Holdings LLC, formally ending its Solana-focused digital asset treasury strategy, which the Board deemed no longer accretive under current market conditions. This move eliminates potential share dilution and redirects capital toward AI, AI agents, and robotics initiatives aligned with its educational technology mission. The company maintains a healthy balance sheet with no imminent liquidity needs and has not sold its existing Solana holdings, which will be evaluated for future divestment.

• ·Announcement date: March 2, 2026
• ·SEC filing date: March 02, 2026
• ·Items reported: 1.02, 9.01

02-03-2026

CCC Intelligent Solutions Holdings Inc. appointed John A. Schweitzer as a Class II Director effective March 2, 2026, leveraging his extensive experience as former EVP, Sales at Salesforce (Informatica division), EVP and Chief Revenue Officer at Informatica, and senior roles at Software AG, Workday, SAP, and Oracle. The Board determined Mr. Schweitzer to be independent under applicable rules and reconstituted the Nominating and Corporate Governance Committee by appointing Teri Williams as chairperson and adding Mr. Eilam and Mr. Schweitzer, resulting in Mr. Wei no longer serving on the committee. Mr. Schweitzer will receive standard non-employee director compensation as detailed in the company's April 8, 2025 proxy statement.

• ·Mr. Schweitzer joined Salesforce in November 2025 via its acquisition of Informatica and served as EVP, Chief Revenue Officer at Informatica from March 2021, including through its IPO in November 2021.
• ·No family relationships, arrangements, or reportable transactions under Item 404(a) of Regulation S-K involving Mr. Schweitzer.

02-03-2026

ITT Inc. completed its $4.775 billion acquisition of SPX FLOW, Inc. on March 2, 2026, integrating 3,900 employees and SPX FLOW's technologies into the renamed Flow Technologies segment, accelerating ITT's 2030 portfolio transformation by four years. SPX FLOW delivered strong 2025 performance with revenue exceeding $1.3 billion and 14% organic orders growth, enhancing ITT's resilience in higher-growth, higher-margin businesses. No declines or flat metrics were reported for SPX FLOW or the combined entity.

• ·Definitive agreement to purchase SPX FLOW announced in December 2025
• ·ITT headquartered in Stamford, Connecticut, with employees in more than 35 countries and sales in approximately 125 countries

02-03-2026

Avalon GloboCare Corp. (NASDAQ: ALBT) announced a private placement priced at-the-market under Nasdaq rules, issuing 6,372,550 shares (or pre-funded warrants) and two series of warrants to purchase up to 6,372,550 shares each at $0.51 per share, expecting $3.25M upfront gross proceeds and up to $6.5M additional if warrants are fully exercised. H.C. Wainwright & Co. acts as exclusive placement agent, with closing expected on or about February 27, 2026, subject to customary conditions; proceeds for debt repayment and working capital. No assurance is given that warrants will be exercised.

• ·Purchase price and warrant exercise price: $0.51 per share
• ·Series A-1 warrants expire five years from stockholder approval; Series A-2 expire eighteen months from approval
• ·Warrants exercisable beginning on effective date of stockholder approval
• ·Securities offered under Section 4(a)(2) and Regulation D to accredited investors; registration rights for resale
• ·Press release dated February 26, 2026; 8-K filing March 02, 2026

02-03-2026

Gyre Therapeutics, Inc. (Nasdaq: GYRE) announced an all-stock agreement to acquire Cullgen Inc. for approximately $300 million, creating a U.S.- and China-based fully integrated biopharmaceutical company with commercial assets like ETUARY® ($105.8M net sales in 2024) and Cullgen's TPD/DAC pipeline targeting inflammatory diseases, cancers, and pain. Leadership will transition with Dr. Ying Luo becoming President and CEO while Ping Zhang remains Executive Chairman; the deal is expected to close early Q2 2026 subject to approvals. Cullgen's prior proposed merger with Pulmatrix was terminated, introducing some prior uncertainty.

• ·Gyre Pharmaceuticals plans NDA submission for Hydronidone in China H1 2026 with conditional approval and priority review eligibility, followed by Phase 3c confirmatory trial.
• ·Cullgen's CG001419 completed Phase 1 for acute pain (positive top-line late 2025), IND submitted for Phase 2 in bunionectomy patients, and in Phase 1 for solid tumors.
• ·Cullgen's CG009301 in Phase 1 for blood cancers including relapsed/refractory AML, higher-risk MDS, and ALL.
• ·Hydronidone received Breakthrough Therapy designation by CDE/NMPA in March 2021.
• ·Updated corporate presentation posted on gyretx.com and cullgen.com.

02-03-2026

Crexendo, Inc. (CXDO) completed the acquisition of Estech Systems, LLC (ESI) for $35M ($27.3M cash and $7.7M stock), at approximately 1.35x ESI's unaudited 2025 revenue of $26M, expected to be immediately accretive to revenue, EBITDA, and cash flow while positioning the combined entity toward a $100M annual revenue run rate. The deal enhances scale with ESI adding over 6,200 retail accounts and 75,000 seats, alongside anticipated cost synergies from infrastructure consolidation and revenue synergies via cross-selling. No negative financial impacts or declines were reported.

• ·Acquisition closed on March 2, 2026; year-end conference call scheduled for March 3, 2026
• ·ESI founded in 1987, headquartered in Plano, Texas
• ·Expected synergies over 12-24 months from facilities consolidation, licensing optimization, and migration to Oracle Cloud Infrastructure

02-03-2026

Virtus Investment Partners, Inc. (NYSE: VRTS) completed its previously announced majority investment in Keystone National Group effective March 1, 2026, expanding its capabilities into private markets with Keystone's asset-backed lending strategies including equipment finance, real estate finance, financial assets, and asset-backed corporate loans. As of December 31, 2025, Keystone managed $2.5B in assets and has invested over $6.0B across more than 750 transactions. CEO George R. Aylward noted the strategic fit with Virtus' multi-boutique model, while Keystone's team retains autonomy and a significant equity stake.

• ·Keystone founded in 2006 and headquartered in Salt Lake City, Utah
• ·Transaction completed effective March 1, 2026

02-03-2026

Allurion Technologies, Inc. received a NYSE notice of delisting due to failure to maintain at least $50M in stockholders’ equity or 30-trading day average market capitalization, triggering potential delisting proceedings. The company intends to appeal the decision, expects shares to continue trading on NYSE during the appeal, and is executing a plan to regain compliance, catalyzed by FDA approval on February 20, 2026, an agreement with its largest creditor to exchange debt for preferred stock, and a warrant inducement on February 24, 2026. While efforts are ongoing, there is no guarantee of regaining compliance or relisting on NYSE or another exchange like NYSE American.

• ·Discussions and negotiations ongoing with existing creditors and security holders, plus capital raising efforts.
• ·Previous announcements: agreement with largest creditor for debt-to-preferred stock exchange at a substantial premium to current trading price (subject to conditions).
• ·SEC filings referenced: 10-K filed March 27, 2025 (amended August 19, 2025); 10-Q filed November 17, 2025.

02-03-2026

Pulse Biosciences, Inc. filed an 8-K/A on March 2, 2026, amending its February 27, 2026 8-K to remove two sentences and report the resignation of Kevin P. Danahy, Chief Commercial Officer, effective immediately on February 27, 2026. No reason for the resignation was provided, and no successor or compensatory details were disclosed. The filing has no financial impacts or other material changes.

• ·Registrant headquartered at 601 Brickell Key Drive, Suite 1080, Miami, Florida 33131.
• ·Common stock trades on Nasdaq under ticker PLSE.

02-03-2026

Forge Global Holdings, Inc. filed an 8-K on March 02, 2026, disclosing completion of an acquisition/disposition (Item 2.01), notice of delisting (Item 3.01), material modification to security holder rights (Item 3.03), changes in control (Item 5.01), director/officer changes (Items 5.02/5.03), and an Amended & Restated Certificate of Incorporation as Exhibit 3.1. The amended certificate drastically simplifies the capital structure to a single class of Common Stock authorized at 100 shares with $0.01 par value, indicating a likely privatization or merger restructuring with no prior period financial comparisons provided.

• ·Registered office: 1209 Orange Street, Wilmington, County of New Castle, Delaware 19808
• ·8-K Items disclosed: 2.01 (Acquisition/Disposition Completion), 3.01 (Delisting Notice), 3.03 (Material Modification to Rights of Security Holders), 5.01 (Changes in Control), 5.02 (Departure/Election of Directors/Officers), 5.03 (Amendments to Articles), 9.01 (Exhibits)

02-03-2026

UnitedHealth Group Incorporated appointed Dennis Stankiewicz, age 48, as Chief Accounting Officer effective March 2, 2026, while he continues serving as Corporate Controller since April 17, 2023. Tom Roos, who has been Chief Accounting Officer since August 2015, will transition to Chief Financial Officer of Optum Insight effective the same date. Stankiewicz's compensation includes an annual base salary of $550,000, an initial cash bonus target of 85% of base salary, and severance of one times base salary upon termination without cause.

• ·Dennis Stankiewicz joined UnitedHealth Group in August 2016 as General Auditor and has more than 24 years of professional experience.
• ·Mr. Stankiewicz has not been involved in any transactions requiring disclosure under Item 404(a) of Regulation S-K.
• ·Severance benefits for Stankiewicz conditioned on non-compete during severance period.

02-03-2026

Rallybio Corporation (RLYB) and Candid Therapeutics announced a definitive merger agreement, with Rallybio acquiring Candid; the combined entity will operate as Candid Therapeutics (CDRX) with pro-forma cash of approximately $700M from over $505M concurrent financing, funding operations through 2030 and advancing TCE pipeline including Phase 2 for cizutamig in 2026. However, pre-merger Rallybio equityholders will own only 3.65% of the combined company (Candid 96.35%), representing significant dilution, while Rallybio shareholders receive CVRs linked to legacy asset sales like REV102.

• ·Merger expected to close mid-2026, subject to stockholder approval, HSR waiting period, and other conditions.
• ·CND319 first-in-human studies planned for mid-2026.
• ·Joint conference call held March 2, 2026 at 8:30 AM ET.

02-03-2026

First Mid Bancshares, Inc. (NASDAQ: FMBH) completed its acquisition of Two Rivers Financial Group, Inc. on March 2, 2026, adding approximately $1.2B in assets, $883M in loans, $1.0B in deposits, and over $1.2B in trust and wealth assets under management across 14 Iowa locations as of December 31, 2025. Post-acquisition, First Mid's total assets stand at $9.1B and total trust and wealth AUM at $7.9B, with no immediate changes for Two Rivers customers and account conversion expected in June 2026. The transaction positions First Mid to expand services in new markets without reported disruptions.

• ·Two Rivers financials reported as of December 31, 2025
• ·Account conversion from Two Rivers expected in June 2026
• ·First Mid operates in Illinois, Missouri, Texas, Wisconsin, and greater Indianapolis area

02-03-2026

On February 27, 2026, The Cannabist Company Holdings Inc. entered into a further extension of a forbearance agreement with an ad hoc group of noteholders holding the Company's 9.25% Senior Secured Notes due December 31, 2028, and 9.00% Senior Secured Convertible Notes due December 31, 2028, extending the forbearance period until March 6, 2026. This prevents noteholders from exercising rights and remedies under the indenture amid presumed covenant or payment issues. The agreement signals ongoing financial pressures with no disclosed resolution or positive developments.

• ·Registrant is an emerging growth company.
• ·Principal executive offices: 321 Billerica Road, Chelmsford, Massachusetts 01824.

02-03-2026

First Financial Corporation (THFF) completed its acquisition of CedarStone Financial, Inc. and CedarStone Bank on March 1, 2026, pursuant to the Merger Agreement dated November 6, 2025. The transaction involved paying $19.12 per share in cash for each share of CedarStone’s common stock, resulting in an aggregate value of approximately $25 million. No financial performance metrics or comparisons were provided in the filing.

• ·Merger Agreement filed as Exhibit 2.1 on November 6, 2025 8-K
• ·CedarStone merged with and into First Financial; CedarStone Bank merged with and into First Financial Bank

02-03-2026

On March 1, 2026, the Board of Directors of Plumas Bancorp adopted a new form of restricted stock unit award agreement under the Plumas Bancorp 2022 Equity Incentive Plan for grants to directors, executives, and employees. The new agreement features time-based vesting tied to continued service, with no cash dividends or dividend equivalents on unvested units—unlike the prior form—entitling participants only to dividends on vested shares. This update is filed as Exhibit 10.1.

02-03-2026

Dakota Gold Corp.'s Board of Directors appointed Brian G. Iverson as a director on February 26, 2026, effective March 1, 2026; he will stand for election by stockholders at the 2026 Annual Meeting of Stockholders. Mr. Iverson will participate in the non-employee director compensation program outlined in the 2025 proxy statement, with no committee assignments determined yet. There are no arrangements, family relationships with directors/officers, or material interests under Item 404(a) of Regulation S-K.

• ·Company address: 106 Glendale Drive, Suite A, Lead, South Dakota 57754
• ·Registrant is an emerging growth company

02-03-2026

Spark I Acquisition Corp held its Annual Meeting on February 25, 2026, with 7,461,944 Ordinary Shares represented, constituting a quorum out of 8,658,251 outstanding (6,236,173 Class A and 2,422,078 Class B as of record date February 5, 2026). Stockholders unanimously elected Kurtis Jang, Shin-Bae Kim, and Ho Min (Jimmy) Kim as Class II directors, each receiving 1,972,078 votes (100% of votes cast with no abstentions or broker non-votes). Proposal 2 to ratify CBIZ CPAs P.C. as independent auditor for fiscal year ending December 31, 2025, also passed unanimously with 7,461,944 votes for (100%).

• ·Directors to serve until 2028 Annual Meeting or until successors elected and qualified
• ·Fiscal year for auditor ratification ends December 31, 2025
• ·No votes withheld, against, abstentions, or broker non-votes on any proposal

02-03-2026

Tata Motors Limited issued a clarification on March 2, 2026, stating that media reports about Indonesia holding vehicle imports from Tata Motors and Mahindra & Mahindra have no material impact, as the 70,000 vehicle order secured by its subsidiary PT Tata Motors Distribusi Indonesia on February 10, 2026, remains on track with advances received and phased deliveries to commence soon. The order, for 35,000 Yodha pick-ups and 35,000 Ultra T.7 trucks, is from PT Agrinas Pangan Nusantara for agricultural and rural logistics support. No undisclosed information or negotiation risks were noted.

• ·Order supports agricultural activities, rural logistics, farm-to-market transportation, and Indonesia’s nation-building efforts.
• ·Company name changed to Tata Motors Limited effective October 29, 2025, post Composite Scheme of Arrangement.
• ·Tata Motors operates in over 40 countries with commercial vehicle portfolio from sub-1-tonne to 60-tonne.

02-03-2026

On February 26, 2026, Erinn Thomas-Mackey resigned from the Board of Directors of Inspire Veterinary Partners, Inc. (IVP), effective immediately, with no disagreement on the company's operations, policies, or practices. The Form 8-K was filed on March 2, 2026, and signed by Kimball Carr, President and Chief Executive Officer.

• ·Company CIK: 0001939365
• ·EIN: 85-4359258
• ·State of Incorporation: Nevada
• ·Trading Symbol: IVP (Common stock, par value $0.0001)

02-03-2026

William J. Renick resigned as a member of the Tennessee Valley Authority Board of Directors on February 24, 2026. Effective March 2, 2026, Jeremy P. Fisher departed from his role as TVA’s Executive Vice President and Chief Business Officer. No information on successors or reasons for departures was provided.

• ·Filing signed by Thomas C. Rice on March 2, 2026

02-03-2026

Purebase Corporation (PUBC) entered into an unsecured $1M line of credit agreement with affiliate CORETER LLC on February 27, 2026, at 8% annual interest, maturing one year later on February 27, 2027. Lender may convert outstanding principal and interest into common stock at maturity based on the weighted average closing price of the prior 20 trading days. Proceeds are designated for payroll, unpaid invoices, and operating expenses; the agreement is unsecured with no immediate advances specified.

• ·Loan advances require 3 business days written notice and are at Lender's sole discretion.
• ·Unsecured obligations; no registration rights for the Note or potential Conversion Shares under Securities Act.
• ·Related-party transaction as CORETER LLC is an affiliate of Borrower.

02-03-2026

Peapack-Gladstone Financial Corporation filed an 8-K/A amendment to its original December 18, 2025 Form 8-K, disclosing committee assignments for newly appointed directors Diane D’Erasmo and Ellen C. Walsh following a Board meeting on February 26, 2026. Ms. D’Erasmo was appointed to the Risk Committee and Technology Committee, while Ms. Walsh was appointed to the Risk Committee and Compensation Committee, with appointments effective immediately. No other changes to the original filing were made.

• ·Original Form 8-K filed on December 18, 2025
• ·Amendment filed on March 2, 2026

02-03-2026

Calavo Growers, Inc. filed an 8-K/A on March 2, 2026, amending its January 14, 2026 8-K to correct a clerical error in Exhibit 10.1 and clarify severance provisions in Executive Retention Agreements entered with CFO James Snyder and Executive VP Ronald Araiza of the Calavo Foods Division. The agreements amend prior offer letters and provide for severance equal to one year of base salary if the executive resigns for Good Reason or is terminated without Good Cause, subject to execution of a release. No other changes or financial impacts were reported.

• ·Agreements amend compensatory provisions of existing offer letters.
• ·Full text of Retention Agreement form filed as Exhibit 10.1.

02-03-2026

On February 25, 2026, Sports Entertainment Gaming Global Corporation (SEGG) appointed Robert Stubblefield, its current CFO, Interim CEO, and President, as a Class II director with term expiring at the 2027 annual meeting, and Daniel Bailey, CEO of Veloce Media Group, as a Class III director with term expiring at the 2028 annual meeting. These appointments are intended to bolster financial leadership, operational continuity, and integration of the recent Veloce acquisition to support the company's sports, entertainment, and gaming strategy. No additional related party transactions with Bailey beyond prior disclosures.

• ·Company address: 5049 Edwards Ranch Rd., 4th Floor, Fort Worth, Texas 76109
• ·Filing signed by Robert J. Stubblefield on March 2, 2026
• ·Emerging growth company status confirmed
• ·Prior related party transaction with Daniel Bailey disclosed in 8-K filed February 23, 2026

02-03-2026

MongoDB reported Q4 FY2026 total revenue of $695.1M, up 27% YoY, and full-year revenue of $2.46B, up 23% YoY, with Atlas revenue growing 29% YoY and customer additions of 2,700 to over 65,200 total. Non-GAAP operating income rose to $158.8M from $112.5M YoY, and free cash flow surged to $176.7M from $22.9M, though GAAP gross margins remained flat at 73% and net income dipped slightly to $15.5M from $15.8M. Leadership changes include Erica Volini joining as Chief Customer Officer effective March 3, 2026, while Cedric Pech and Paul Capombassis are departing.

• ·Q1 FY2027 guidance: GAAP loss from operations $(48.0)M to $(44.0)M; non-GAAP $105.0M to $109.0M.
• ·FY2027 guidance: GAAP loss from operations $(117.0)M to $(97.0)M; non-GAAP $545.0M to $565.0M.
• ·Paul Capombassis to remain CRO through Q1 FY2027 and serve as advisor in Q2.

02-03-2026

LSI Industries Inc. (Nasdaq: LYTS) announced a proposed $90 million public offering of common stock, with a 30-day underwriter option for up to an additional 15% of shares, to fund its growth strategy including the Royston Group acquisition (merger agreement dated February 20, 2026, expected to close in Q3 FY2026) and repayment of borrowings under a January 21, 2026 credit facility. Proceeds may also support general working capital. The announcement highlights forward-looking risks such as market conditions, integration challenges, and economic factors, with no current performance metrics provided.

• ·Agreement and Plan of Merger dated February 20, 2026
• ·Senior Secured Credit Facility Commitment Letter dated January 21, 2026
• ·Expected Royston Group acquisition close in third quarter of LSI’s 2026 fiscal year
• ·Oppenheimer & Co. and Craig-Hallum acting as joint lead book-running managers
• ·LSI headquartered in Cincinnati with 18 manufacturing plants in US and Canada

02-03-2026

Booz Allen Hamilton Inc. entered into the Eleventh Amendment to its Credit Agreement on February 27, 2026, establishing $1B in new Refinancing Revolving Commitments (replacing existing ones), $750M in new Refinancing Tranche A-2 Term Loans to partially repay existing Tranche A Term Loans, and $500M in Supplemental Revolving Commitments, resulting in total Revolving Commitments of $1.5B. Existing Revolving Loans and part of Existing Tranche A Term Loans will be repaid in full or in part on the Effective Date, with waivers of certain prepayment penalties. No material negative impacts or declines in financial metrics are disclosed.

• ·Existing Revolving Commitments and Revolving Loans to be terminated/repaid on Eleventh Amendment Effective Date.
• ·Proceeds of $750M New Refinancing Tranche A-2 Term Loans used solely to repay part of Existing Tranche A Term Loans.
• ·Waivers of prepayment losses/expenses for Term SOFR Loans prepaid before end of Interest Period.
• ·Letters of Credit outstanding to remain in place post-termination of Existing Revolving Commitments.
• ·Effectiveness subject to no Default/Event of Default, true representations/warranties, and payment of fees.

02-03-2026

Sunbelt Rentals Holdings, Inc. (NYSE: SUNB) announced the commencement of trading its common stock on the NYSE under ticker SUNB, completing the transition to a U.S. primary listing with a secondary listing retained on the London Stock Exchange; former Ashtead Group plc shareholders received one Sunbelt share per Ashtead share held. The company, with 24,000 employees across more than 1,600 locations and a fleet exceeding $19B, highlighted its leadership in North American equipment rentals amid growing industry demand. No financial declines or flat metrics were reported, positioning Sunbelt for enhanced U.S. capital market access and growth.

• ·Earnings call scheduled for March 12, 2026 at 8:30 a.m. Eastern Time
• ·Investor Day on March 26, 2026 to cover strategic roadmap, performance, and capital allocation
• ·Registration Statement on Form 10 filed February 13, 2026

02-03-2026

On February 24, 2026, Christopher J. Klein notified Vontier Corporation's Board of his decision to retire as a director effective at the 2026 Annual Meeting of Shareholders, where he will not stand for re-election. This follows his support during the Company's spin-off and is not due to any disagreement with the Company's operations. The 8-K was filed on March 2, 2026.

• ·Company's principal executive offices: 5438 Wade Park Boulevard, Suite 600, Raleigh, NC 27607
• ·I.R.S. Employer Identification No.: 84-2783455

02-03-2026

Integrated Wellness Acquisition Corp, a SPAC, held its Business Combination Meeting on December 8, 2025, where shareholders approved the proposed business combination with Btab Ecommerce Group, Inc. However, the deal has not yet closed, prompting the company to file a proxy on February 23, 2026, for an Extension Meeting on March 12, 2026, to extend the business combination deadline from March 16, 2026, to September 16, 2026. Public shareholders can redeem shares at an estimated $12.91 per share (as of December 31, 2025), with instructions available via the transfer agent.

• ·Business Combination Proxy Statement filed November 12, 2025; Extension Proxy Statement filed February 23, 2026.
• ·Extension Meeting record date: February 18, 2026.
• ·Shareholders may withdraw redemption requests prior to the Extension Meeting vote or thereafter with company consent.

02-03-2026

BiomX Inc. reported the resignation of CFO Marina Wolfson and Chief Development Officer Dr. Merav Bassan on February 24, 2026, followed by the resignations of directors Greg Merril, Edward Williams, and Susan Blum on February 25, 2026, with none resulting from disagreements over operations, policies, or practices. The Board appointed David Rokach, with prior experience as CEO of Newcom Finance and Granit Investment Company, as the new CFO effective February 27, 2026. Separately, the Special Meeting of Stockholders was adjourned due to lack of quorum on February 25, 2026, and will reconvene on March 11, 2026.

• ·Record date for Special Meeting remains February 3, 2026.
• ·Special Meeting to reconvene virtually at www.virtualshareholdermeeting.com/PHGE2026SM, 8:00 a.m. Eastern Time.
• ·No arrangement or family relationships involving new CFO David Rokach requiring disclosure under Items 401(d) or 404(a) of Regulation S-K.

02-03-2026

On March 2, 2026, the Compensation Committee of the Board of Directors of Reliance Global Group, Inc. (NASDAQ: EZRA) approved and ratified a one-time cash bonus of $50,000 for Joel Markovits, the Company's Chief Financial Officer, subject to tax withholding and deductions. The filing pertains to Item 5.02 under compensatory arrangements for certain officers, with no departures, elections, or appointments reported.

• ·Securities registered: Common Stock (EZRA, par value $0.086 per share) and Series A Warrants (EZRAW) on The NASDAQ Capital Market.
• ·Company address: 300 Blvd. of the Americas, Suite 105, Lakewood, New Jersey 08701.
• ·IRS Employer Identification No.: 46-3390293.

02-03-2026

Seres Therapeutics, Inc. announced executive leadership transitions effective March 2, 2026, appointing Board member Richard N. Kender as Executive Chair and Interim Chief Executive Officer, Matthew Henn, Ph.D. as President (in addition to Chief Scientific Officer), and Kelly Brady, M.S. as Executive Vice President and Chief Operating Officer. Former Co-Presidents and Co-CEOs Thomas J. DesRosier and Marella Thorell transitioned to Executive Vice President, Chief Legal Officer and Executive Vice President, Chief Financial Officer roles, respectively, providing continuity in key functions amid the change.

• ·Options vest monthly or quarterly over 4 years, with 25% contingent on stockholder approval of 2025 Incentive Award Plan amendment by 2026 annual meeting.
• ·Signing/retention bonuses subject to repayment if employment ends before December 31, 2026 for cause or without good reason.
• ·No family relationships or material interests required to be disclosed under Regulation S-K Items 401(d) or 404(a).

02-03-2026

Fidus Investment Corporation entered into Amendment No. 3 to its Equity Distribution Agreement, increasing the maximum aggregate offering amount under its at-the-market (ATM) program from $300.0M to $400.0M. As of March 2, 2026, approximately $134.8M remains available for sale through sales agents Fidus Investment Advisors, LLC, Raymond James & Associates, Inc., and B. Riley Securities, Inc. No shares were sold in connection with this amendment.

• ·Original Equity Distribution Agreement dated November 10, 2022
• ·Prospectus supplement filed March 2, 2026 (accompanying prospectus dated February 27, 2026)
• ·Shelf registration on Form N-2 (File No. 333-293856)

02-03-2026

MariMed Inc. entered into a Restructuring and Exchange Agreement dated February 24, 2026, with Navy Capital Green entities, cancelling existing promissory notes totaling $4.4175M and surrendering 4,908,333 Series B shares valued at $14.725M to avoid mandatory conversion or redemption provisions due February 28, 2026. In exchange, the Company issued new promissory notes for an $8M loan ($2M Note 1 and $6M Note 2, guaranteed by subsidiaries) and 26,900,000 new Series B Convertible Preferred shares. While this provides restructuring flexibility and new liquidity, it introduces additional debt and significant potential equity dilution.

• ·Existing Shares issued originally at $3.00 per share and convertible 1:1 into common stock.
• ·New Series B Preferred Stock issuance upon filing amended Series B Certificate of Designation with Delaware Secretary of State.
• ·Company to pay Navy's costs, expenses, and fees within 3 business days of Effective Date.
• ·Transactions exempt from registration under Regulation D and state securities laws.

02-03-2026

DHI Group, Inc. (NYSE: DHX) announced the acquisition of Point Solutions Group, an engineering and technology professional services firm in defense contracting, for $5.5 million, including $5.0 million upfront cash and $0.5 million potential earn-out based on 2026 revenue thresholds. The deal enables ClearanceJobs to bid on federal contracts, provide staffing solutions for cleared roles, and expand its market beyond job postings. No financial impacts or declines were disclosed in the announcement.

• ·Acquisition announced on March 2, 2026
• ·Point Solutions Group holds Top Secret facility clearance and past performance on U.S. Department of Defense and intelligence community contracts
• ·Earn-out achievable within one year of purchase date

02-03-2026

Dave Inc. reported record Q4 2025 revenue of $163.7 million, up 62% YoY from $100.9 million, and FY 2025 revenue of $554.2 million, up 60% YoY from $347.1 million. GAAP net income grew 292% to $66.0 million in Q4 and 238% to $195.9 million for the year, while Adjusted EBITDA increased 118% to $72.9 million in Q4 and 162% to $226.7 million annually, though quarterly GAAP net income showed volatility with a 16% decline in Q1 2025. The company provided FY 2026 guidance for revenue growth of 25%-28% to $690-$710 million and raised its share repurchase authorization from $125 million to $300 million.

• ·Q4 2025 Non-GAAP Gross Profit Margin of 74%, up 300 bps YoY.
• ·Q4 2025 average 28-day past due rate improved 12% QoQ to 1.89%.
• ·Q4 2025 Dave Debit Card spend increased 17% YoY to $534 million.
• ·Q4 2025 ExtraCash Monetization Rate Net of Losses at record 4.8%, up 29 bps YoY.
• ·FY 2026 Adjusted EBITDA guidance $290-$305 million; Adjusted EPS $14.00-$15.00.

02-03-2026

Asana, Inc. (NYSE: ASAN) announced the promotion of Aziz Megji to Chief Financial Officer (CFO) effective March 24, 2026, succeeding Sonalee Parekh, who has served as CFO since 2024 and will resign effective March 23, 2026. CEO Dan Rogers praised Megji's contributions to financial strategy and go-to-market execution, expressing confidence in his leadership for growth in the Agentic Enterprise. The company notes more than 180,000 organizations use Asana, including Accenture, Amazon, Anthropic, and Suzuki.

• ·Aziz Megji joined Asana in 2024 as Head of Financial Planning & Analysis, overseeing annual planning, budgeting, forecasting, treasury, investor relations, corporate development, and sales compensation.
• ·Filing date: March 02, 2026
• ·Parekh tendered resignation effective March 23, 2026

02-03-2026

Newbridge Acquisition Limited, a blank check company, entered into a non-binding Memorandum of Understanding (MOU) with Starcoin Group Limited (formerly Innovative Pharmaceutical Biotech Limited, HKEX: 399) on February 27, 2026, to explore a potential de-SPAC transaction involving Starcoin and/or its assets or businesses. The MOU requires due diligence and definitive agreements to proceed and terminates 180 days after signing unless extended. No transaction is guaranteed, and shareholders are advised to exercise caution when dealing in the Company's securities.

• ·MOU termination: earlier of definitive agreements or 180 days after February 27, 2026
• ·Company securities: NBRGU (Units), NBRG (Class A Ordinary Shares), NBRGR (Rights) listed on Nasdaq
• ·Starcoin listed on The Stock Exchange of Hong Kong Limited (stock code 399)

02-03-2026

Kevin R. Sayer is returning from a temporary leave of absence effective March 2, 2026, to resume his role as Executive Chairman of DexCom, Inc., following his planned retirement from CEO effective January 1, 2026. Under a new letter agreement effective the same date, he will receive an annual base salary of $610,000 and restricted stock units valued at $2.35M vesting on March 8, 2027, while remaining eligible for executive benefit plans except the Severance & Change in Control Plan. Mark Foletta will resume duties as Lead Independent Director upon Sayer's return.

• ·Kevin R. Sayer's prior equity awards continue to vest per original terms.
• ·Temporary leave of absence began September 14, 2025.

02-03-2026

Bakkt Holdings, Inc. announced the pricing of a $48.125M registered direct offering of 3,024,799 shares of Class A common stock and pre-funded warrants to purchase 2,475,201 shares at approximately $8.75 per share/warrant to a single institutional investor, expected to close on or around March 2, 2026. Gross proceeds will fund working capital, general corporate purposes, and strategic initiatives, with Cohen & Company Capital Markets as sole placement agent. No comparative financial metrics were provided, and the announcement includes extensive forward-looking risk disclosures but no quantitative declines.

• ·Offering pursuant to shelf registration statement on Form S-3 (File No. 333-288361) effective July 3, 2025.
• ·Pricing announced February 27, 2026; expected closing on or around March 2, 2026, subject to customary conditions.
• ·Pre-funded warrants have $0.0001 per share exercise price.

02-03-2026

Pitney Bowes Inc. completed a $150M offering of additional 7.250% Senior Notes due 2029 on March 2, 2026, which form a single series with $326M of original notes issued in 2021, increasing total outstanding Notes to $476M. The company received net proceeds of approximately $146.9M, to be used for general corporate purposes including repayment, repurchase, or refinancing of other indebtedness. The notes are senior unsecured obligations guaranteed by certain U.S. subsidiaries.

• ·Interest payable semi-annually in arrears on March 15 and September 15; first payment for Additional Notes on March 15, 2026, including accrued interest from September 15, 2025.
• ·Notes mature on March 15, 2029, unless earlier repurchased or redeemed.
• ·Issued pursuant to Original Indenture dated March 19, 2021, supplemented by First Supplemental Indenture dated March 2, 2026.

02-03-2026

On March 2, 2026, My Size, Inc. received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2), as the closing bid price fell below $1.00 for 30 consecutive business days. The company has 180 calendar days until August 31, 2026, to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days, with potential for an additional 180 days if other listing standards are met. The Notification Letter has no immediate effect on trading, but failure to comply could lead to delisting proceedings, and the company may consider a reverse stock split.

• ·Trading symbol: MYSZ
• ·State of incorporation: Delaware
• ·Commission File Number: 001-37370
• ·IRS Employer Identification No.: 51-0394637
• ·Principal executive offices: HaNegev 4, POB 1026, Airport City, Israel 7010000
• ·Telephone: +972-3-600-9030

02-03-2026

On March 1, 2026, AI Era Corp. accepted the resignation of Chiyuan Deng as Chief Executive Officer (effective immediately, with no disagreements noted; he continues as President, Chief Financial Officer, and Director) and appointed Ahmad Moradi, an AI technology veteran with over 25 years of leadership experience across multiple companies, as the new CEO. Both executives entered into three-year employment agreements featuring $500,000 and $300,000 sign-on bonuses (payable in stock), $144,000 annual base salaries, $30,000 remote work stipends, and stock option grants of 2 million and 1.5 million shares respectively; the Board also adopted the 2026 Incentive Plan reserving 10 million shares. No financial performance metrics or declines were reported in the filing.

• ·Employment agreements include 12-month non-competition/non-solicitation covenants in AI-driven media/entertainment sector (U.S.-wide).
• ·Stock sign-on bonuses calculated at per-share price of $0.80-$1.00.
• ·Performance incentives eligible up to 1,250,000+ shares for Moradi and 750,000+ for Deng, tied to revenue growth, partnerships, KPIs.
• ·Severance for Moradi: 150% of remaining base salary; for Deng: 125%.
• ·Chiyuan Deng signed the filing as President on March 2, 2026.

02-03-2026

Lifeward Ltd. (LFWD) completed a 1-for-12 reverse share split effective February 24, 2026, reducing outstanding Ordinary Shares from 18,339,098 to approximately 1,528,098 to comply with Nasdaq Capital Market's $1.00 minimum bid price listing requirement. The company simultaneously adopted its Eighth Amended and Restated Articles of Association, increasing authorized Ordinary Shares from 75,000,000 to 100,000,000. Outstanding warrants and stock options were proportionately adjusted.

• ·Shareholder approval at Extraordinary General Meeting on January 6, 2026.
• ·Finance Committee approved 1-for-12 ratio on January 30, 2026, and amendments on February 16, 2026.
• ·Trading on split-adjusted basis began February 24, 2026, under symbol LFWD with new CUSIP M8216Q309.
• ·No fractional shares issued; fractions rounded down.

02-03-2026

Constellation Acquisition Corp I drew $5,000 in Extension Funds from an unsecured promissory note with Constellation Sponsor LP on February 27, 2026, depositing them into its trust account to extend the initial business combination deadline from February 28, 2026, to March 29, 2026. This marks the first of eleven permitted one-month extensions. No declines or flat metrics reported, providing additional time without immediate liquidation risk.

• ·Promissory note originally dated January 30, 2024; interest-free and matures upon initial business combination closing.
• ·Note repayment only from amounts outside trust account if no business combination consummated.
• ·Company is a blank check (SPAC) incorporated in Cayman Islands, emerging growth company.

02-03-2026

On February 25, 2026, the Board of Directors of Goldman Sachs BDC, Inc. reduced its size from seven to six members due to a vacancy from a director's retirement effective December 31, 2025. To balance director classes per the company's certificate of incorporation, Timothy J. Leach and Katherine P. Uniacke were reclassified and appointed as Class III directors, with Leach retaining his role as Chairman of the Board and multiple committees.

• ·Class III directors will hold office until the 2026 annual meeting of stockholders or until successors are elected.
• ·Neither Leach nor Uniacke has family relationships with current directors or officers, nor any material transactions under Item 404(a) of Regulation S-K.

02-03-2026

Voya Financial, Inc. completed a $400M registered public offering of 5.050% Senior Notes due 2036 on March 2, 2026, fully guaranteed by its wholly-owned subsidiary Voya Holdings Inc., yielding net proceeds of approximately $395.2M after commissions and expenses. Proceeds are intended for general corporate purposes, potentially including repayment of the $447M outstanding 3.65% Senior Notes due June 15, 2026. No declines or flat metrics reported in this debt issuance event.

• ·Notes issued under Base Indenture dated July 13, 2012, supplemented by Tenth Supplemental Indenture dated March 2, 2026.
• ·Interest payable semi-annually on March 2 and September 2, beginning September 2, 2026.
• ·Voya may redeem Notes in whole or in part at any time at prices specified in Supplemental Indenture.
• ·Underwriting Agreement dated February 23, 2026, with Citigroup Global Markets Inc., BofA Securities, Inc., and Wells Fargo Securities, LLC as representatives.

02-03-2026

Datadog, Inc.'s Board of Directors increased its size from 10 to 11 members and appointed Dominic Phillips as a Class II director on February 26, 2026, with his term expiring at the 2027 Annual Meeting of Stockholders. Mr. Phillips will receive compensation under the Amended and Restated Non-Employee Director Compensation Policy, with his initial restricted stock unit grant increased from $400,000 to $600,000 as an inducement, vesting in three equal annual installments over three years. No arrangements, family relationships, or material interests pursuant to Item 404(a) of Regulation S-K were disclosed.

• ·Mr. Phillips not expected to join any Board committee at this time.
• ·Proxy statement describing Director Compensation Policy filed April 18, 2025.
• ·No arrangement or understanding pursuant to which Mr. Phillips was selected as director.

02-03-2026

Realty Income Corporation announced that Executive Vice President, Chief Legal Officer, General Counsel and Secretary Michelle Bushore is leaving the company to pursue new opportunities, but will remain in her role through September 2, 2026, to ensure a smooth transition while a search for her successor is conducted. CEO Sumit Roy praised her contributions, including key M&A negotiations and governance enhancements, amid the company's portfolio of over 15,500 properties as of December 31, 2025. The departure represents a leadership change, though her extended tenure mitigates immediate disruption.

• ·Founded in 1969
• ·NYSE listing in 1994
• ·Portfolio spans all 50 U.S. states, the United Kingdom, and eight other European countries
• ·Known as 'The Monthly Dividend Company®'

02-03-2026

On February 25, 2026, Live Oak Acquisition Corp. V appointed Somak Chivavibul, age 59, as a Class I independent director, effective immediately, with membership on the audit committee and as chair of the compensation committee. Mr. Chivavibul brings over 25 years of public company financial management experience from roles at Navient Corporation (CFO 2014-2017), Sallie Mae, and Ernst & Young. No family relationships or disclosable transactions under Item 404(a) of Regulation S-K exist with the director.

• ·Appointment includes joinder to letter agreement dated February 27, 2025 (amended November 14, 2025) and indemnification agreement similar to those of existing officers/directors.
• ·Company is a Cayman Islands exempted company, emerging growth company, listed on Nasdaq (LOKVU, LOKV, LOKVW).

02-03-2026

MSC Industrial Supply Co. (NYSE: MSM) announced on March 2, 2026, the election of Reuben Slone as an independent member of its Board of Directors. Chairman Mitchell Jacobson praised Slone's supply chain expertise from prior C-level roles at Advance Auto Parts (EVP, Supply Chain 2018-2023) and Walgreens Boots Alliance (SVP, Supply Chain Management for six years), expecting positive impacts on operations, customer service, and financial performance. MSC highlighted its scale with approximately 2.5 million products and over 7,000 associates.

• ·Slone graduated from the University of Michigan with a BS in Engineering.
• ·Slone served as EVP, Supply Chain at Advance Auto Parts from 2018 to 2023.
• ·Slone served six years as SVP, Supply Chain Management at Walgreens Boots Alliance, overseeing integration of Rite Aid stores and distribution centers.
• ·Slone currently serves on the board of American Tire Distributors.

02-03-2026

KeyCorp announced that Chief Information Officer Amy G. Brady informed the company of her resignation effective March 2, 2026, due to personal health considerations, with a transition period as a non-executive employee through May 31, 2026. Under the Transition Letter dated March 2, 2026, Ms. Brady will receive one year of salary continuation and benefits post-termination, eligibility for 2026 incentive compensation, and continued vesting in her Capital and Earnings Improvement Award granted December 30, 2024, subject to a release of claims. The departure is structured for an orderly transition with no quantified financial impacts disclosed.

• ·Event reported date: February 24, 2026
• ·Transition Letter filed as Exhibit 10.1

02-03-2026

Tilray Brands, Inc. completed the acquisition of select BrewDog assets, including the global brand, UK brewing operations, and 11 brewpubs, for £33 million, expected to generate ~$200M in annual net revenue and ~$6-8M Adjusted EBITDA in fiscal 2027, creating a ~$500M global craft beer and beverage platform with Tilray's total annualized revenue reaching ~$1.2B. The deal advances Tilray's global beverage strategy and is accretive, with cash flow positivity expected in fiscal 2027. However, no meaningful EBITDA contribution is anticipated in Q4 fiscal 2026 due to licensing transfer timelines, and early fiscal 2027 brewing revenues may face temporary timing differences.

• ·Separately negotiating US and Australia BrewDog assets, expected to close in ~30 days
• ·Conference call scheduled for March 2, 2026 at 12:30pm ET
• ·Acquired brewpubs: Birmingham, Canary Wharf, Dogtap Ellon, Dublin, Edinburgh DogHouse, Lothian Road, Manchester, Paddington, Seven Dials, Tower Hill, Waterloo
• ·Advisors: Jefferies LLC (financial), Proskauer Rose LLP (legal)

02-03-2026

Northann Corp. received NYSE American acceptance on February 24, 2026, of its compliance plan submitted by January 7, 2026, granting until June 8, 2027, to regain compliance with continued listing standards under Section 1003(a)(i) of the Company Guide. While the company's common stock (NCL, $0.001 par value) remains listed and traded with no immediate impact on operations or SEC reporting, failure to meet progress goals or full compliance by the deadline could trigger delisting proceedings. The company affirmed its intent to pursue all reasonable measures during this Plan Period, following an initial non-compliance notice on December 11, 2025.

• ·Initial non-compliance notice filed December 11, 2025
• ·Company is an emerging growth company
• ·Principal executive office: 2251 Catawba River Rd., Fort Lawn, SC 29714
• ·Trading symbol: NCL on NYSE American LLC

02-03-2026

HA Sustainable Infrastructure Capital, Inc. issued $400M aggregate principal amount of 6.000% Green Senior Unsecured Notes due 2036 on March 2, 2026, under an amended indenture dated June 24, 2025. Net proceeds will temporarily repay borrowings under the revolving credit facility, commercial paper programs, or redeem outstanding 8.00% Senior Notes due 2027, with ultimate allocation to eligible green projects within two years. The Notes are senior unsecured obligations guaranteed by key subsidiaries, with semi-annual interest payments starting September 15, 2026, and maturity on March 15, 2036.

• ·Base Indenture dated June 24, 2025; Officer’s Certificate dated March 2, 2026.
• ·Optional redemption: prior to Dec 15, 2035 at 100% principal plus make-whole premium; on/after Dec 15, 2035 at 100% principal.
• ·Interest payable semi-annually on March 15 and September 15, commencing September 15, 2026.

02-03-2026

TON Strategy Company (TONX) terminated Rory J. Cutaia, CEO of its Global Digital Media Division and a named executive officer, on February 26, 2026, effective February 27, 2026. Mr. Cutaia subsequently resigned from the Board on March 1, 2026, effective immediately, citing disagreements with the Board's governance, oversight, fiduciary duties, and allegations of corporate waste and self-dealing. The 8-K was filed on March 2, 2026, and signed by Sarah Olsen, CFO and COO.

• ·Company incorporated in Nevada, CIK 0001566610, EIN 90-1118043.
• ·Principal executive offices at 3024 Sierra Juniper Ct., Las Vegas, Nevada 89138.
• ·Telephone: (855) 250-2300.

02-03-2026

Targa Resources Corp. completed a public offering of $750M aggregate principal amount of 4.350% Senior Notes due 2031 and $750M aggregate principal amount of 6.050% Senior Notes due 2056, totaling $1.5B in senior unsecured notes guaranteed by certain subsidiaries. The notes were issued under an indenture dated April 6, 2022, as supplemented on March 2, 2026, with U.S. Bank Trust Company, National Association as trustee. Net proceeds will be used for general corporate purposes, including repaying commercial paper borrowings, other indebtedness, repurchasing securities, capital expenditures, working capital, or subsidiary investments.

• ·Prospectus Supplement dated February 25, 2026, filed February 26, 2026
• ·Base Indenture dated April 6, 2022

02-03-2026

On February 24, 2026, the Nasdaq Listing and Hearing Review Council affirmed the Nasdaq Hearings Panel's decision to delist Graphjet Technology's Class A ordinary shares due to failures under Listing Rules 5450(b)(2) (market value of listed securities) and 5450(b)(3)(C) (market value of publicly held shares), with delisting effective November 13, 2025. Despite the company's appeal on November 25, 2025, proposing compliance under Rule 5450(b)(1) with at least $10M stockholders' equity and $5M market value of publicly held shares, the decision was upheld with no path to reinstatement noted. This represents a significant negative development with no offsetting positive metrics.

• ·Trading suspended on Nasdaq on November 13, 2025.
• ·Panel delisting determination dated November 11, 2025.
• ·Appeal filed November 25, 2025 (Docket No. NQ 7187N-25), acknowledged November 26, 2025.
• ·Company incorporated in Cayman Islands; principal offices in Shah Alam, Selangor, Malaysia.
• ·Emerging growth company status confirmed.

02-03-2026

Neuronetics, Inc. entered into a Second Amendment to the Registration Rights Agreement with Madryn Asset Management LP and its affiliates (the 'Madryn Parties') on March 2, 2026, stemming from the prior Arrangement Agreement with Greenbrook TMS Inc. The amendment obligates Neuronetics to file a Registration Statement for resale of all Registrable Securities owned by the Madryn Parties within five business days after filing its Annual Report on Form 10-K for the year ended December 31, 2025, upon receipt of a Shelf Notice. In exchange, the Madryn Parties commit to voting their Neuronetics shares at the 2026 annual meeting in accordance with the Board of Directors' recommendations on specified proposals.

• ·First Amendment to Registration Rights Agreement executed on November 1, 2024
• ·Original Registration Rights Agreement executed August 13, 2024
• ·Second Amendment attached as Exhibit 10.1

02-03-2026

Acrivon Therapeutics, Inc. mutually terminated its OncoSignature Companion Diagnostic Agreement with Akoya Biosciences (a Quanterix subsidiary), dated June 17, 2022, effective February 25, 2026, with no financial payments exchanged. The termination enables transition of ACR-368 OncoSignature testing to Acrivon's newly certified in-house CLIA laboratory, completed February 18, 2026, providing full control over development, biomarkers, and commercialization rights. Quanterix will support ongoing clinical testing needs during the transition for Acrivon's registrational-intent Phase 2b study.

• ·Termination involves transfer of all procedures, materials, and know-how from Akoya to Acrivon
• ·Supports streamlining of co-regulatory approvals and co-commercialization of therapeutics and diagnostics

02-03-2026

Vista Gold Corp. announced a proposed underwritten public offering of US$30.0 million in common shares, with a 30-day underwriter option for up to an additional US$4.5 million to cover over-allotments, led by CIBC Capital Markets. Net proceeds are intended for exploration and development at the Mt. Todd gold project in Australia and general corporate purposes. The offering is subject to market conditions, TSX approval, and other factors, with no assurance of completion or final terms.

• ·Shelf registration on Form S-3 (No. 333-282706) filed October 17, 2024, effective November 8, 2024.
• ·Offering also in Canadian provinces except Quebec under listed issuer financing exemption.
• ·Closing subject to TSX approval under Section 602.1 exemption.

02-03-2026

Brinker International, Inc. (NYSE: EAT) promoted George Felix to Executive Vice President, Chief Marketing Officer, overseeing marketing for both Chili’s Grill & Bar and Maggiano’s Little Italy, effective March 2, 2026. Felix, who joined in 2022 as SVP and CMO of Chili’s, contributed to the company's market capitalization growing from $1.3B to $6.25B during his tenure. No declines or flat metrics were reported in the announcement.

• ·Brinker operates in 31 countries and two U.S. territories.
• ·Felix received awards including Fast Company’s 2025 CMOs of the Year, Ad Age 2025 CMO of the Year, and ADWEEK 2024 Marketing Vanguard.

02-03-2026

Fortitude Gold Corp. (OTCQB: FTCO) entered a Joint Venture Agreement with Hawthorne Land & Minerals, LLC to form East Camp Douglas, LLC, funded by Hawthorne's $40M investment for 40% ownership while Fortitude retains 60% majority interest and operational control. The investment supports an aggressive exploration program aiming for a major gold discovery within 1-2 years, parallel permitting for up to 125 acres disturbance, and fast-tracked mine development. No declines or flat performance metrics reported in current operations.

• ·Property located in Silver Star mining district, Mineral County, Nevada, ~6 miles southwest of Mina.
• ·Consists of 293 unpatented lode claims, 24 unpatented placer claims, 12 patented mining claims, and 3 fee land parcels.
• ·Ongoing exploration under two active Notices of Intent (NOIs) for limited 5-acre disturbance while permitting progresses.
• ·Year-end conference call to discuss JV to be announced separately.

02-03-2026

Mid Penn Bancorp, Inc. (NASDAQ: MPB) completed its acquisition of 1st Colonial Bancorp, Inc. on February 27, 2026, in a cash-and-stock transaction valued at approximately $106.1 million, merging 1st Colonial Community Bank into Mid Penn Bank and expanding its footprint into the greater Philadelphia area and southern New Jersey. The combined company now has approximately $7 billion in consolidated assets and 62 retail locations. Thomas R. Brugger, former director of 1st Colonial, was appointed as a director of Mid Penn and Mid Penn Bank.

• ·Acquisition completed after close of business on February 27, 2026; filing dated March 2, 2026
• ·Keefe, Bruyette & Woods served as exclusive financial advisor to Mid Penn; Stephens Inc. to 1st Colonial

02-03-2026

WaFd, Inc. (Nasdaq: WAFD), parent of WaFd Bank, appointed Erin Hill to its Board of Directors on March 2, 2026. Ms. Hill brings over 30 years of experience in financial services, including roles as Executive Director of the Financial Accounting Foundation (parent of FASB and GASB), Chief Administrative Officer at BNY Mellon (safeguarding $40T in assets), and Head of Consumer Banking at JP Morgan Chase. CEO Brent Beardall highlighted her expertise in finance, audit, governance, and leadership of large teams as invaluable for WaFd Bank's strategic priorities.

• ·WaFd Bank established in 1917 with branches in Washington, California, Oregon, Idaho, Nevada, Utah, Arizona, New Mexico, and Texas.
• ·Ms. Hill's education: Juris Doctor (Columbia University School of Law), M.B.A. (Columbia Business School), B.S. in Accounting (Fordham University, magna cum laude).
• ·Ms. Hill is a Certified Public Accountant and member of National Association of Corporate Directors, American Bar Association, American Institute of Certified Public Accountants.
• ·Contact: Brad Goode, 206-626-8178, Brad.Goode@wafd.com

02-03-2026

FB Bancorp, Inc. (NASDAQ: FBLA)'s subsidiary, Fidelity Bank, completed the sale of certain assets of its NOLA mortgage division to First Federal Bank on March 1, 2026, pursuant to an Asset Purchase Agreement dated December 31, 2025. The transaction was previously disclosed, and no financial terms or impacts were detailed in the filing.

• ·Asset Purchase Agreement dated December 31, 2025
• ·Fidelity Bank located in New Orleans, Louisiana
• ·First Federal Bank located in Lake City, Florida

02-03-2026

Kratos Defense & Security Solutions, Inc. (KTOS) announced a proposed underwritten public offering of $1B in common stock pursuant to an effective shelf registration, with underwriters holding a 30-day option for up to an additional $150M in shares. Net proceeds are expected to fund customer-targeted acquisitions, investments and capital expenditures for national security programs and pipeline opportunities, and general corporate purposes. The offering is subject to market and other conditions, with no assurance of completion.

• ·Shelf registration on Form S-3ASR (File No. 333-293786) automatically effective February 26, 2026.
• ·Joint book-running managers: Baird, Raymond James, RBC Capital Markets, Truist Securities.
• ·Announcement date: February 26, 2026; 8-K filing date: March 02, 2026.

02-03-2026

Resolute Holdings Management, Inc. converted from a Delaware corporation to a Nevada corporation and adopted new Articles of Incorporation effective upon filing. The new articles authorize 1,100,000,000 total shares (1,000,000,000 Common Stock and 100,000,000 Preferred Stock, both with $0.0001 par value), establish a classified board of up to 12 directors divided into three classes, and include provisions limiting stockholder actions by written consent and special protections tied to 'Investor' ownership exceeding 40% of voting power. No financial performance metrics or period-over-period changes are reported.

• ·Filing Date: March 02, 2026
• ·No cumulative voting for Common Stock
• ·Directors may only be removed for cause by 2/3 vote of voting power
• ·Board authorized to fill vacancies without stockholder vote
• ·No preemptive or subscription rights for Common Stock holders
• ·Trigger Date occurs when Investors cease to beneficially own 40% of voting power

02-03-2026

On March 1, 2026, CarMax, Inc. entered into amended and restated severance agreements with certain executive officers, including named executives Enrique Mayor-Mora, Charles Joseph Wilson, and Shamim Mohammad, superseding their prior agreements. The new agreements provide severance benefits of 1.5 times the sum of base salary and target bonus (payable in 39 biweekly installments) plus up to 18 months of COBRA premium payments, triggered by termination without cause or resignation for good reason within two years of a change in control. All other terms remain substantially similar to prior agreements.

• ·Form of Amended and Restated Severance Agreement attached as Exhibit 10.1.
• ·Definitions of 'cause', 'good reason', and 'change in control' as specified in the new agreement.

02-03-2026

Omnicom Group Inc. closed public offerings of $1.7B in U.S. Dollar-denominated senior notes ($400M 4.200% due 2029, $700M 5.000% due 2033, $600M 5.300% due 2036) and €600M 3.850% senior notes due 2034 issued by subsidiary Omnicom Finance Holdings plc, generating net proceeds of ~$1.68B and ~€594.5M. Proceeds will primarily repay $1.4B of 3.600% senior notes due April 15, 2026 (outstanding as of Dec 31, 2025), with remainder for general corporate purposes including acquisitions, debt repayment, and stock repurchases. The notes are unsecured senior obligations with standard covenants, redemption options, and change of control repurchase rights at 101%.

• ·U.S. Notes interest payable semi-annually: Mar 2/Sep 2 for 2029 Notes (commencing Sep 2, 2026); Jun 2/Dec 2 for 2033/2036 Notes (commencing Jun 2, 2026).
• ·Euro Notes interest payable annually on May 2 (commencing May 2, 2026).
• ·Redemption: U.S. Notes make-whole prior to Feb 2, 2029 (2029 Notes)/Apr 2, 2033 (2033)/Mar 2, 2036 (2036) at gov't bond rate +15-20 bps; par thereafter. Euro Notes make-whole prior to Feb 2, 2034 at +20 bps; par thereafter.
• ·Underwriting agreements dated Feb 25, 2026; U.S. Notes Indenture dated Mar 2, 2026; Euro Notes Second Supplemental Indenture dated Mar 2, 2026.
• ·Euro Notes listing application approved by NYSE.

02-03-2026

BGSF, Inc. appointed Keith Schroeder and Kelly Brown as permanent Co-Chief Executive Officers. On February 24, 2026, subsidiary B G Staff Services, Inc. entered into an Executive Employment Agreement with Ms. Brown, providing an initial annualized base salary of $375,000 through December 31, 2027, with eligibility for EBITDA-based annual bonuses, 1% acquisition bonuses, discretionary incentives, and severance of 12 months base salary (18 months post-change of control). Additional agreements include non-disclosure, non-compete (12 months), non-solicitation (18 months), and indemnification.

• ·Severance includes COBRA premiums for 18 months upon qualifying termination.
• ·Full vesting of equity awards upon qualifying termination.
• ·Non-compete restricted for 12 months post-termination; non-solicitation and non-interference for 18 months.
• ·Prior disclosure incorporated from 8-K filed June 23, 2025.

02-03-2026

Duos Technologies Group, Inc. (Nasdaq: DUOT) announced the commencement of an underwritten public offering of common stock (or equivalents) to expand and commercialize its Edge Data Center business, with proceeds also for working capital and general corporate purposes. Titan Partners, a division of American Capital Partners, is the sole bookrunner, and the offering includes a potential 30-day underwriter option for additional shares. However, the offering is subject to market conditions with no assurance of completion, timing, size, or terms.

• ·Shelf registration statement on Form S-3 (File No. 333-293372) filed February 11, 2026, declared effective February 12, 2026.
• ·Preliminary prospectus supplement to be filed with SEC and available at www.sec.gov.
• ·Contact for prospectus: Titan Partners Group LLC, 4 World Trade Center, 49th Floor, New York, NY 10007, (929) 833-1246, prospectus@titanpartnersgrp.com.
• ·Websites: www.duostech.com, www.duosedge.ai, www.duosenergycorp.com.

02-03-2026

Keen Vision Acquisition Corp. entered into a binding Letter of Intent (LOI) on February 26, 2026, with Medera Inc. and its wholly-owned subsidiary Novoheart Group Limited (NVH) to negotiate and execute a replacement merger agreement by April 10, 2026, following the termination of a prior merger agreement dated September 3, 2024, due to volatility and cautious sentiment in the US biotechnology sector. The LOI sets NVH's enterprise valuation at $100M and requires at least $10M in available liquidity at closing after capping transaction expenses at $0.7M for Parent and $1.3M for NVH, with the deal structure to be optimized for tax efficiency. However, the prior agreement's termination highlights ongoing market challenges, and the LOI will terminate if no replacement is signed by the deadline.

• ·Prior Merger Agreement dated September 3, 2024, terminated concurrently with LOI execution via mutual release.
• ·PIPE fundraising, if pursued, must close within 9 months of LOI signing; Replacement Merger Agreement terminates if closing conditions not met within 9 months of LOI.
• ·Promissory notes to KVC Sponsor LLC subject to mutually agreed maximum cap (Note Cap) to be detailed in Replacement Merger Agreement.
• ·NVH currently has no external liabilities; internal liabilities to be converted to equity prior to closing.
• ·Medera China Company Limited and subsidiaries excluded from business combination.

02-03-2026

CrossAmerica Partners LP (NYSE: CAPL) announced Maura Topper, current CFO, as the new President and CEO of CrossAmerica GP LLC effective March 2, 2026, succeeding Charles Nifong who served in the role since November 19, 2019, and is transitioning to the executive team of affiliate Dunne Manning Holdings LLC. Jonathan E. Benfield was appointed Interim CFO effective the same date. The announcement highlights Nifong's past achievements in strategic pivots and major transactions while expressing confidence in Topper's leadership for future growth.

• ·Maura Topper served as CFO since August 11, 2021, VP and CFO of Dunne Manning from 2014, and Board member from IPO in 2012 to October 2014 and November 2019 to present.
• ·Dunne Manning founded in 2014, manages Topper family office portfolio.
• ·CrossAmerica Partners LP formed in 2012, ranks as one of ExxonMobil’s largest distributors by fuel volume and top 10 for other major brands.

02-03-2026

L3Harris Technologies (NYSE: LHX) appointed Kenneth (Ken) Sharp as Senior Vice President and Chief Financial Officer effective March 16, 2026, bringing over 30 years of financial leadership experience from Peraton Inc., DXC Technology, and Northrop Grumman’s Defense Systems. Ken Bedingfield will transition to focus exclusively on leading the Missile Solutions segment, scaling solid rocket motor manufacturing, and preparing for its initial public offering later in 2026. CEO Christopher Kubasik praised the appointments for enhancing leadership amid urgent defense demands.

• ·Ken Sharp, age 55, began his career as an auditor at Ernst & Young and is a Marine Corps veteran who served in Operations Desert Shield and Desert Storm.
• ·Missile Solutions IPO is forward-looking and subject to market conditions, regulatory developments, and risks related to proposed transaction with the Department of War.

02-03-2026

Broadcom Inc. announced that Director Eddy W. Hartenstein will retire from the Board at the conclusion of his term during the 2026 annual meeting of stockholders, in line with the company's Corporate Governance Guidelines upon reaching age 75; the retirement is not due to any disagreement with the company. The Board size will be reduced to eight members following the Annual Meeting.

• ·Event reported on February 24, 2026; filing dated March 2, 2026
• ·Retirement pursuant to Corporate Governance Guidelines for age 75

02-03-2026

Iterum Therapeutics plc received a Nasdaq delisting determination on February 24, 2026, for noncompliance with the $1.00 minimum bid price rule and other standards including the $35M minimum market value of listed securities, shareholders' equity, and net income requirements. Ordinary shares face suspension from Nasdaq trading effective March 5, 2026, unless the company appeals to a hearings panel. The company is evaluating strategic alternatives, including potential wind-down, bankruptcy, or liquidation, where shareholders are unlikely to receive meaningful returns.

• ·Compliance period for Minimum MVLS Requirement extends until June 9, 2026.
• ·Nasdaq intends to file Form 25-NSE with SEC after appeal periods lapse.
• ·Company may file Form 15 to suspend reporting obligations post-delisting.

02-03-2026

CNS Pharmaceuticals, Inc. appointed Lynne Kelley as Chief Medical Officer effective March 2, 2026, under an employment agreement with an initial annual base salary of $450,000, a target annual bonus of 40% of base salary, and an initial grant of 9,500 restricted stock units. Concurrently, former Chief Medical Officer Dr. Sandra Silberman separated from the company on February 27, 2026, receiving severance equal to three months of her current annualized base salary, paid in monthly installments. Dr. Kelley brings extensive prior experience as CMO at multiple biotech firms including Tissium, Inc. and X4 Pharmaceuticals, Inc.

• ·New CMO RSUs vest 25% on six-month anniversary, 25% on twelve-month anniversary, and remaining 50% in twelve quarterly installments thereafter.
• ·Severance for former CMO payable in three equal monthly installments, subject to execution of release and compliance.
• ·Employment agreement dated February 26, 2026; Separation agreement dated February 27, 2026.

02-03-2026

TriplePoint Venture Growth BDC Corp. entered into a Master Note Purchase Agreement dated February 27, 2026, authorizing the issuance and sale of $75M aggregate principal amount of 7.50% Series 2026 Senior Notes due February 27, 2028. The notes include provisions for interest rate adjustments upward by 1.00% upon a Below Investment Grade Event or Secured Debt Ratio Event, providing flexibility but potential cost increases for the company.

• ·Agreement filed as Exhibit 10.1 in 8-K on March 02, 2026.
• ·SEC filing items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Financial Statements and Exhibits).
• ·Below Investment Grade Event defined based on ratings from NRSROs; company required to maintain at least one Investment Grade rating per Section 9.8.
• ·Secured Debt Ratio calculated excluding SBIC Subsidiaries, with pro forma adjustments for projected cash from asset sales, equity, or unsecured debt within 60 days.

02-03-2026

Bausch Health Companies Inc. announced on February 26, 2026, amendments to 2023 performance share unit (PSU) award agreements for named executive officers Thomas Appio (1,137,862 PSUs) and Seana Carson (137,922 PSUs), changing settlement from stock to cash equal to the market price of common stock on the March 3, 2026 vesting date. The Talent and Compensation Committee approved the amended Appio Agreement, while the Carson Agreement involves her irrevocable disposition of PSUs under Canadian tax rules. Full agreements will be filed in the upcoming Form 10-Q for the quarter ending March 31, 2026.

• ·2023 PSUs originally granted in March 2023 and earned over a three-year performance period.
• ·Appio Agreement amended and restated by the Talent and Compensation Committee.
• ·Carson Agreement authorized under paragraph 7(1)(b) of the Income Tax Act (Canada).

02-03-2026

Oregon Energy LLC, a uranium exploration company 100% owned by Aurora Energy Metals Limited, reported total assets of $443,089 as of December 31, 2025, up 2.9% from $430,549 at June 30, 2025, with member's capital rising to $441,521 amid a $14,946 net income for the six months ended December 31, 2025 versus a $66,005 loss YoY, boosted by $117,869 other income. However, cash plummeted 89.6% to $1,733, exploration expenses surged 79% YoY to $86,575, the three-month period showed a widened net loss of $17,443 versus $15,543 YoY, and substantial going concern doubts persist due to low liquidity.

• ·Holds mining claims covering approximately 43 square kilometers.
• ·Restricted cash of $140,960 posted as bonds for reclamation with BLM and DOGAMI.
• ·Going concern doubt raised due to $1,733 cash balance and accumulated deficit of $13.4M; dependent on additional financing.
• ·Reclamation obligation fully settled at $0 as of Dec 31, 2025.

02-03-2026

Great Elm Capital Corp. (GECC) reported Q4 2025 total investment income of $12.6M, up 19% QoQ from $10.6M, with NII of $0.31 per share surging over 50% QoQ from $0.20, driven by higher cash distributions from CLO JV. However, net assets fell to $112.9M or $8.07 per share from $140.1M or $10.01 per share QoQ due to $26.4M in net realized and unrealized losses ($1.88 per share), and asset coverage declined to 158.1% from 168.2%. The company appointed Jason Reese as Executive Chairman, waived $2.3M in incentive fees (pro forma NAV $8.23/share), declared a $0.30/share Q1 2026 dividend (19.2% annualized yield), and repurchased/called GECCO notes reducing outstanding to ~$19M post-Q1.

• ·Weighted average current yield on new investments deployed Q4 2025: 8.1%; on monetized investments: 9.3%.
• ·Total expenses Q4 2025: $8.2M or $0.58 per share, including excise tax.
• ·Pro forma asset coverage ratio ~166.0% as of Dec 31, 2025 after fee waiver and note call.
• ·Q1 2026 dividend payable Mar 31, 2026 to record date Mar 16, 2026.

02-03-2026

Fortress Value Acquisition Corp. V, a blank check company sponsored by an affiliate of Fortress Investment Group LLC, announced the pricing of its $250M initial public offering of 25,000,000 Class A ordinary shares at $10.00 per share, with trading on Nasdaq under ticker FVAV beginning February 26, 2026. Deutsche Bank Securities Inc. serves as the sole underwriter, with a 45-day option to purchase up to an additional 3,750,000 shares for over-allotments. The registration statement was declared effective by the SEC on February 25, 2026.

• ·SEC registration statement declared effective on February 25, 2026.
• ·45-day underwriter option to cover over-allotments.

02-03-2026

Banner Corporation (NASDAQ: BANR) appointed Monica O’Reilly and Judith Steiner to its Board of Directors effective March 1, 2026, with both also joining the Banner Bank board. O’Reilly, with over 30 years in financial services including as Vice Chairman at Deloitte, will serve on the Corporate Governance/Nominating and Risk Committees; Steiner, former Banner Bank Chief Risk Officer (2016-2021), will serve on the Credit Risk and Risk Committees. CEO Mark Grescovich highlighted their expertise in compliance, risk, cybersecurity, and AI as key to strengthening the board for long-term growth.

• ·O’Reilly recognized as one of the 'Most Influential Women in Business' by San Francisco Business Journal (2021); holds B.A. from Queen’s University Belfast and Wharton Executive Leadership Program.
• ·Steiner holds Juris Doctor from Case Western Reserve University and B.A. from University of Akron; prior roles at FirstMerit included General Counsel and Secretary.

02-03-2026

Graco Inc. (NYSE: GGG) announced the appointment of Sanjiv Gupta as Chief Financial Officer and Treasurer effective April 15, 2026, succeeding David M. Lowe, who will retire after more than 30 years of service with the company. Gupta joins from General Motors Company (NYSE: GM), bringing over 20 years of finance and operational experience, including as Vice President & Chief Financial Officer, GM International. Lowe, age 70, will remain available through the end of May 2026 to ensure a seamless transition.

• ·David M. Lowe joined Graco in 1995 and served as CFO since 2021.
• ·Sanjiv Gupta previously held roles as Executive Director, Corporate Financial Planning and Analysis, and President and Managing Director, GM India.
• ·Gupta holds a Bachelor of Engineering from Thapar University and MBA from Western University’s Ivey School of Business.

02-03-2026

On February 25, 2026, directors Charles W. Henry and Michael J. Mardy announced they will not stand for re-election at the 2026 Annual Meeting of Shareholders and will retire upon term expiration, with the Board reducing its size from eight to six members; the departures were not due to any disagreements. Concurrently, the Board amended the Bylaws to enhance certain shareholder rights, such as reducing the supermajority vote threshold for shareholder amendments from 75% to a simple majority and lowering the special meeting ownership requirement from 35% to 25% with added procedural safeguards including one-year continuous ownership.

• ·Shareholder notice window for annual meeting proposals/nominations adjusted to 90-120 days before anniversary of prior year's meeting.
• ·Special meeting requests require one-year continuous ownership and detailed proposal text.
• ·Bylaws eliminate mandatory executive committee and clarify Chairman role as non-officer position.